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After a long time of coevolution between mitochondria and their eukaryotic 
host cells, the mitochondrial genome has diverged severely from it’s α-
proteobacterial ancestors. Mitochondrial genes have mainly been transferred 
to the cytosolic genome and only a small number of highly hydrophobic core 
subunits of the oxidative phosphorylation system (OXPHOS) have been 
retained within the mitochondrial genome. 
Since the OXPHOS consist of subunits of both mitochondrial and cytosolic 
origins, the translation of mitochondrial proteins has to be coordinated with the 
translation and import of proteins translated on cytosolic ribosomes to provide 
efficient assembly of the OXPHOS subunits.  
One mechanism to regulate mitochondrial translation by cytosolic events is 
via regulators for mitochondrial translation. Such proteins are present during 
mitochondrial translation and can either interact with mitochondrial mRNAs, or 
associate with the mitochondrial ribosome. Even though many mitochondrial 
translation regulators are well characterized in yeast, little is known about 
them in human mitochondria. 
In this thesis, I was able to isolate the ribosome-associated early assembly 
intermediate of the cytochrome c oxidase, MITRAC, during the translation of 
COX1. Western blot and mass spectrometry analysis showed the presence of 
the insertase OXA1L within this complex and cryoEM analysis could localize 
the complex near the exit tunnel of the mitochondrial ribosome. 
In a second part, MITRAC15, which was characterized as a MITRAC subunit 
and a subunit of the PP-b early assembly intermediate, was functionally 
characterized. MITRAC15 could be shown to be a positive translation 
regulator of ND2 and is the first identified protein to possibly copurify with 
nascent chains of mitochondrial complex I proteins after puromycin treatment. 
Furthermore, it was shown that MITRAC15 is able to stall the assembly of the 






1.1 Mitochondria structure and function 
 
Mitochondria are cell organellescommonly known as the “powerhouses of the 
cell”. Although existing within eukaryote cells for over 2 billion years (Hedges 
et al., 2004), the earliest records that described mitochondrial like structures 
dates back to the 1840s. These structures were first recognized first by 
Richard Altmann in 1890 and were titled “bioblasts”. The present name, 
formed by the Greek words “mitos” (thread) and "chondros" (granule), was 
introduced by Carl Benda in 1897 to describe the appearance of those 
organelles during spermatogenesis.The most established theory explaining 
the origin of mitochondria is the endosymbiosis theory. It states that 
mitochondria originate from an α-proteobacterium (symbiont), which was 
ingested and thus annexed by an unidentified primitive eukaryotic host cell 
(Sagan, 1967;Yang et al., 1985). 
The structure and physiology of mitochondria is strongly influenced by the 
origin of the organelle. Unlike other compartments in the eukaryotic cell, 
mitochondria possess two different membranes. The mitochondrial outer 
membrane (OM), whichseparates the organelle from the cytosol and the 
mitochondrial inner membrane (IM), which surrounds a compartment called 
the mitochondrial matrix. A second compartment exists between the OM and 
IM of mitochondria: the intermembrane space (IMS). While IM and matrix are 
compartments derived from the α-proteobacterialsymbiont, OMand IMS 
originate from the eukaryotic host cell (Frey and Mannella, 2000). Additionally 
there are foldings of the IM, creating secluded areas within the IMS called 
“cristae”. Cristae are the localization of theoxidative phosphorylation system 
(OXPHOS), which is responsible for the most well known task of 











Figure 1 General structure and different compartments of mitochondria. 
Besides providing the cell with energy in the form of ATP, mitochondria are 
also involved in a number of other important functions. They take part in 
catabolic metabolism pathways like β-oxidation of fatty acids(Eaton et al., 
1996),the urea cycle(Mori et al., 1982), or the citric cycle(van der Bliek et al., 
2017). Mitochondria are also involved in the biogenesis of iron sulfur clusters 
(Cardenas-Rodriguez et al., 2018),or different signalling pathways like calcium 
signalling and apoptosis(Tait and Green, 2012;Rizzuto et al., 2012). Due to 
the diversity of functions associated with mitochondria, they have been 
implicated in a variety of diseases.Diseases result from mutations in the 
mitochondrial genome and/or mutations in nuclear encoded mitochondrial 
proteins like Parkinson’s disease (examples of affected proteins: Pink1, 
parkin)(Winklhofer and Haass, 2010) or Leigh syndrome (examples of 
affected proteins: LRPPRC, ND1 – 6) (Gerards et al., 2016). 
 
1.1.1 The Oxidative phosphorylation system 
 
One of the crucial traits all eukaryotes share is the ability to perform aerobic 
respiration. The reaction behind aerobic respiration is called oxidative 
phosphorylation and is carried out by the oxidative phosphorylation system 
(OXPHOS) in mitochondria, which consists of four complexes (I – IV), coupled 
to the ATP generating system (complex V).  
The net chemical reaction of the OXPHOS is a rather simple one. Electrons 




energy stored in the electrons 
IMS and the mitochondrial matrix. The proton gradient can 
generate one of the basic energy providing compounds in eukaryotic cells: 
ATP. 
Electrons are firstdelivered from the citric cycle
dehydrogenase (complex I)
oxidoreductase (complex II)
oxidation of NADH by complex I causes a concomitant release of protons 
across the inner membrane and into the inner membrane space. In contrast, 
complex II has the same target for electron tr
releases less energy, it does not transfer protons. Both complexes transfer 
electrons to ubiquinone (Q). R
c oxidoreductase (complex III) and the electrons are transferred to 
cytochrome c while protons are transferred to the IMS
last complex participating in the chemical reaction is the cytochorome 
oxidase (complex IV). Here the electrons of the cytochrome 
transferred to oxygen, 
across the inner membrane
protons into the inner membrane space, resulting from complex I, III and IV, 
generates a proton gradient which
(complex V) to synthesize ATP 
 
Figure 2 The Oxidative phosphorylation system (OXPHOS).
complex I and II by NADH and FADH
IV to be used for the reduction of oxygen to water. Electron transport processes in the 
complexes I, III and IV generate a proton gradient, which is used by complex V to generate 
ATP 
 of electron transport is highly complex
is used to create a proton gradient between
then 
, either via NADH to the NADH 
, or via succinate to the Succinate
(Fiedorczuk et al., 2016;Cecchini, 2003)
ansfer but as the reaction 
educed ubiquinone isoxidized by Q
(Berry et al., 2000)
reducing it to water and again transferring protons 
(Castresana et al., 1994). The accumulation of 
 is used by the F1F0ATP synthase 
(Mitchell and Moyle, 1968) (Figure 
 Electrons are delivered to 
















OXPHOS complexes tend to associate with each other to form so called 
“supercomplexes”. This was first reported by Schägger et al, whereby 
OXPHOS complexes and supercomplexes were resolved using BN-PAGE 
(Schägger and Pfeiffer, 2000). Heterogenic respiratory supercomplexes 
containing different OXPHOS complexes can be divided into 3 different 
species: I + III2, III2+IV1-2, I+III2+IV1-4.Additionally, complex III and IV are able 
to form homodimers (Letts and Sazanov, 2017). Supercomplexes possibly 
enable a higher efficiency in electron transfer (Bianchi et al., 2004) and 
reduce the production of ROS in mitochondria (Lopez-Fabuel et al., 2016). In 
the case of human and mouse mitochondria, the stability of complex I is 
dependant on supercomplex formation (Acin-Perez et al., 2004;Diaz et al., 
2006). Also complex V can form homodimers which have membrane shaping 




Figure 3 Different forms of supercomplexes in human mitochondria. 
 
1.2 Protein synthesis in mitochondria 
 
Due to their α-proteobacterial origin, mitochondria posses a functional system 
for transcription, translation and replication within the matrix. However, unlike 
the α-proteobacteria, mitochondria are not able to express the enzymes of the 
translation system and have to import nuclear encoded factors from the 
cytosol (Hällberg and Larsson, 2014). Most parts of the mitochondrial 
transcription and translation system have undergone a number of 
mitochondrial-specific adaptions, since their α-proteobacterial origin,which 





1.2.1 The mitochondrial genome 
 
With over 1000 identified mitochondrial proteins in mammals, and over 800 in 
yeast, mitochondria require a large variety of different proteins to maintain 
their functionality (Meisinger et al., 2008). While the α-proteobacterium was 
able to survive on its own and expressed a full set of essential elements with 
over 3600 genes (Lerma et al., 2015), the mitochondrial genome only 
encodes for a small subset of proteins, as well as functional RNA. 
Mitochondrial DNA was remodelled with their eukaryotic host cells in 
coevolutional events. Since those evolutional events occurred independently 
within lineages, mitochondrial genomes are highly diverse between species. 
Therefore, the number of mitochondrial genes can vary from over 100 genes 
in jakobids to only a few in parasitic protists (Burger et al., 2003). 
Despite occurring independently between species, the evolution of the 
mitochondrial genome displays some common principles. Due to a mutation 
rate which is much higher than autosomes (45 times higher for human), 
mitochondrial genomic evolution is a relatively rapid process (Fu et al., 2014). 
The mutational events have lead to a general decrease of the mitochondrial 
genome, while the genes deleted in mitochondria were moved to the nucleus 
(Burger et al., 2003). Additionally, mitochondrial DNA has a high adenine, 
thymine content.This composition is suggested to be beneficial for the 
oxidative environment, because oxidative damage on A and T will lead to 
more tolerable mismatched base pairings(Martin, 1995). Two mitochondrial 
genes, which are present in all eukaryotic species, are COX1 and CYTb. Von 
Heijne et al. speculate that this is due to their strong hydrophobic nature 
which would restrict their import into mitochondria (Heijne, 1986).  
Since mitochondrial DNA is exclusively maternally inherited (Kaneda et al., 
1995) and hence, cannot undergo sexual recombination, it is highly 
susceptible to the accumulation of harmful mutations over time (Muller’s 
ratchet, (Muller, 1964)). In mammals, several poorly understood mechanisms 
exist to counteract this development and ensure mitochondrial fitness: (a) 
Only a subset of the mtDNA pool is transferred to the next generation, 
because of a bottleneck phenomenon (Hauswirth and Laipis, 1982): (b) A 




removesmtDNA mutations that lead to amino acid substitutions (Stewart et al., 
2008): (c) A mechanism exist in developing embryos, which selects against 
mutations within mitochondrial tRNA (Stewart et al., 2008): (d) Females with 
high levels of mutations in mtDNA have decreased fertility.(Freyer et al., 
2012).  
The human mitochondrial DNA is double stranded, with a size of 16.6 kb. It 
encodes 9 monocistronic and 2 bicistronic mRNAs, which translates into 13 
core subunits of the OXPHOS complexes I, III, IV and V. Additionally, the 
mitochondrial DNA encodes for 2 ribosomal RNAs (12S and16S rRNA) and 
22 t-RNAs (Hällberg and Larsson, 2014). The two strands of mitochondrial 
DNA differ in their base composition. One is rich in guanines and therefore 
possesses a higher molecular mass. Thus the two strands can be separated 
by density centrifugation in alkaline CsCl2 gradients and are labelled as the 
light (L) and heavy (H) strand historically (Berk and Clayton, 1974). Even 
though both the L and the H strand encode functional elements, most of the 
genetic information is stored in the H strand. The L strand only codes for 7 
tRNAs, the replication primer for the H strand, and the complex I subunit ND6. 
All other proteins, tRNAs, as well as the 12S and 16S rRNA, are encoded by 
the H strand (Hällberg and Larsson, 2014). The heavy-strand promoter (HSP) 
and the light-strand promoter (LSP) are both localized in a non-coding area of 
the mitochondrial DNA that also contains the origin of replication for the H 






Figure 4 Organization of the mitochondrial genome.The non-coding regions are coloured 
in grey. The regions coding for the mitochondrial rRNA are coloured in red. The regions 
coding for tRNAs are coloured in blue. The regions coding for mitochondrial proteins are 
coloured in orange. 
Similar to bacterial DNA (Dame et al., 2012), mtDNA are densely packed into 
small structures called nucleoids. In mammals, mtDNA molecules with a 
length of approximately 5 µm (Nass, 1966) are packed into nucleoids with a 
diameter of around 100 nm (Kukat and Larsson, 2013). These nucleoids 
contain an average number of 1.4 copies of mtDNA molecules (Kukat et al., 
2011). The major player in the maintaining the mtDNA nucleoid structure is a 
protein named mitochondrial transcription factor A (TFAM). TFAM is a protein 
that belongs to the high mobility group (HMG)-box family, which enables it to 
bind DNA (Malarkey and Churchill, 2012). It is able to pack mtDNA into 
compact nucleoids alone via a cooperative binding mode, where one 




condensation of the DNA molecule increase the more TFAM interacts with it. 
Beside its function in mtDNA structure, TFAM is also required for the initiation 
of mitochondrial transcription, described below (Yakubovskaya et al., 2014). 
 
1.2.2 Transcription and maturation of mitochondrial RNA 
 
Mitochondrial transcription is carried out by the mitochondrial RNA 
polymerase (POLRMT) and bears little similarity to the process in mammalian 
or bacterial transcription, but rather resembles transcription in the 
bacteriophage T7. The mammalian POLRMT is related to the RNA 
polymerase encoded by the bacteriophage T7 (RNAP) and possesses an N-
terminal domain (amino acids 368 – 647) with similarity to the AT-rich 
recognition loop in T7 RNAP, which is needed for promoter binding (Ringel et 
al., 2011). POLRMT possesses two other characteristic domains: the C-
terminal catalytic domain (amino acids 647 – 1230) (Ringel et al., 2011) and 
the N-terminal extension (amino acids NTE, 42 – 368), a unique feature within 
the POLRMT that has an unknown function (Schwinghammer et al., 2013). 
Unlike the T7 RNAP, the N-terminal domain (amino acids 368 – 647) in 
POLRMT does not participate in promoter binding, but rather functions during 
transcription elongation by separating RNA from DNA (Schwinghammer et al., 
2013). 
The initiation of mitochondrial transcription takes place in the promoter 
regions containing LSP and HSP by the formation of an initiation complex on 
one of the promoters. The initiation complex consists of 3 components; TFAM, 
which is responsible for creating a characteristic U-turn in the DNA that 
facilitates POLRMT binding (Yakubovskaya et al., 2014); the mitochondrial 
transcription factor B2 (TFB2M), which forms part of the catalytic site together 
with POLRMT and is required for structural changes in the initiation complex 
(Posse et al., 2014); and finally, POLRMT itself. Once elongation starts, the 
mitochondrial transcription elongation factor (TEFM) interacts with the 
catalytic C-terminal domain of POLRMT (Minczuk et al., 2011). TEFM 
stimulates the interaction of POLRMT with the DNA:RNA template, assists in 




lesions, which can cause premature termination of transcription (Posse et al., 
2015;Agaronyan et al., 2015). The mechanism of mitochondrial transcription 
termination is still enigmatic. A family of potential termination factors that 
facilitate DNA unwinding were identified and are known as the Mitochondrial 
Transcription Termination Factors (MTERFs). However, only MTERF1 can be 
loosely related to translation termination (Yakubovskaya et al., 2010). The 
other 3 known members of this family (MTERF 2 – 4) are associated with 
other functions, like negative transcription regulation (MTERF3) (Park et al., 
2007), or mitochondrial monosome assembly (MTERF4-NSUN4 heterodimer) 
(Metodiev et al., 2014). MTERF2 shows association with the mitochondrial 
nucleoid but it’s function still has to be determined (Pellegrini et al., 2009).  
Both the L and the H strand are each transcribed into a large polycistronic and 
intron-free RNA molecule, which is then further processed to release the 
functional elements. The mitochondrial mRNA and rRNA are mainly flanked 
by tRNAs, which are also the initiation points for processing. The mRNA and 
rRNA are released from the flanking tRNAs according to the widely accepted 
tRNA punctuation model (Ojala et al., 1981). Processing of the polycistronic 
transcript happens in small distinct locations referred to as mitochondrial RNA 
granules (MRG) (Jourdain et al., 2013). These granules contain the 5’-
processing machinery known as RNase P, which consist of 3 subunits 
(MRPP1 – 3). While MRPP1 and MRPP2 form a stable complex (Jourdain et 
al., 2013), MRPP3 only interacts transiently with this complex (Rossmanith, 
2008). The MRPP1-MRPP2 complex performs the N1-methylation of the 9th 
position in the tRNA (m1R9), which is critical for obtaining the tRNA specific 
cloverleaf fold (Vilardo et al., 2012). During this modification, MRPP3 will join 
the RNase P complex and trim the 5’ end of the tRNA (Rossmanith, 2008). 
The 3’ processing subsequently occurs outside of the MRGs and is carried 
out by the RNase Z, ELAC2 (Jourdain et al., 2013;Brzezniak et al., 2014). 
Once processed, the CCA acceptor stem is added onto the tRNA, by the 
CCA-adding enzyme (Reinhard et al., 2017). During the whole maturation 
procedure, the tRNA is associated with the MRPP1-MRPP2 complex, which 
can enhance ELAC2 enzyme activity (Reinhard et al., 2017).  
Besides the N1-methylation at position 9, mitochondrial tRNA also harbours 




the overall structure of the tRNA, or are crucial for codon-anticodon 
interaction. A common modification that facilitates codon-anticodon interaction 
during decoding is a methyl-taurine modification located on a Uracil base at 
the C5 wobble position (Kurata et al., 2003). A further example for a 
structurally relevant modification is the pseudouridination of position U27 and 
U28 in several tRNAs (tRNAK, tRNAM, tRNAL, tRNAI, and tRNAD), which serve 
to stabilize and order of the anticodon stem loop(Agris, 2008). Still, one of the 
most crucial modifications happens at the C34 position of tRNAM. Besides 
decoding for the universal start codon AUG and AUA(Anderson et al., 1981), 
which encodes for isoleucine outside mitochondria, in both translation 
initiation and elongation, the tRNAM has also to be able to decode the 
mitochondrial specific start codons AUU and AUC(Fearnley and Walker, 
2002). Formylation at the position C34 in tRNAM was shown to be crucial for 
the recognition of the AUA codon(Takemoto et al., 2009) and is also 
considered assist with the AUU and AUC codon(Boos et al., 2016). 
In most cases, the mitochondrial mRNA is released as a consequence of 
tRNA processing. However, exceptions include, ND5/CYTB and 
ATP6+ATP8/COX3, which are not flanked by tRNA. The mechanism 
underlying their processing remains enigmatic (Hällberg and Larsson, 2014). 
Once released, mRNAs undergo posttranscriptional modifications to stabilize 
them and initiate translation. Unlike cytosolic mRNA, mammalian 
mitochondrial mRNA often lacks, or has an extremely short 5’ and 3’ UTR 
(Hällberg and Larsson, 2014). Furthermore, the typical 7-methylguanosine 
cap at the 5’ end of the mRNA is not present, which is essential for translation 
initiation in lower eukaryotes (Cowling, 2009). The only known modification of 
mitochondrial mRNA are short polyA tails (45 – 50 nt) at the 3’ end (Ojala et 
al., 1981). Those polyA tails are present in all mitochondrial mRNAs, with the 
exception of ND6, which is immediately competent for translation after 
liberation from the polycistronic primary transcript of the L strand (Temperley 
et al., 2010). Yeast mitochondrial mRNA differs from mammalian in the 
context of UTR’s, since mitochondrial mRNA in yeast do contain 5’ and 3’ 





Figure 5 Transcription in mitochondria.
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1.2.2.1 Stability of mitochondrial mRNA
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Another more indirect player in mitochondrial mRNA stability is the protein 
pair, LRPPRC/SLIRP. These two proteins form a heterodimer via an 
interaction between the 3 pentatricopeptide repeat (PPR) motifs of LRPPRC 
and the RNA recognition motif (RRM) of SLIRP (Spåhr et al., 2016). The 
heterodimeric complex enhances mRNA stability by impairing the degradation 
via SUV3/PNPase and promoting the activity of mtPAP (Chujo et al., 2012). 
While the LRPPRC harbours mRNA binding ability and prevents the 
accumulation of secondary structures, SLIRP does not bind mRNA despite 
the RRM domain and is rather necessary to stabilize LRPPRC (Spåhr et al., 
2016), (Siira et al., 2017). 
 
1.2.3The mitochondrial ribosome 
 
Mitochondrial ribosomes are largely different from their bacterial ancestors. 
Since the evolutional events took place individually in different lineages, 
mitochondrial ribosomes display specific differences. Despite this, general 
trends are also noticeable for most of the lineages. (a) Until the divergence of 
the metazoan, there was a trend in the expansion of mitochondrial 
rRNA.Nevertheless, the evolution of the metazoan was accompanied by a 
reduction of mitochondrial rRNA (van der Sluis et al., 2015). This feature was 
most dominant within mammals, who posses a mt-rRNA length of only 2532 
bp, which is about half the length of bacterial rRNA (4458 bp) or yeast  (4941) 
mt-rRNA (Greber and Ban, 2016). (b) In contrast to the declining 
mitochondrial rRNA, there was an expansion in the number of mitochondrial 
ribosomal proteins, which increased from 54 in the bacterial ribosome to 82 in 
the mitochondrial ribosomes of mammals and yeast (Greber and Ban, 2016).  
Research into mitochondrial ribosomes made crucial progress upon the 
generation of structural data by cryoEM. The first structure of the 55S 
monosome was provided by the lab of Rajendra K. Agrawal (Sharma et al., 
2003), with a resolution of 12 – 14  Å. With the improvement of cryoEM 
technology over the years, mitochondrial ribosomal structures were obtained 
with a much higher resolution (Bai et al., 2015), including a 4.9 Å resolution 




subunit (Greber et al., 2014)  and a 3.2 Å structure of the yeast 54S 
mitochondrial ribosomal large subunit (Amunts et al., 2014). Today, atomic 
structures also exist for monosomes of mitochondria in human (3.5 Å (Amunts 
et al., 2015)) (Figure 6), pig (3.8 Å (Greber et al., 2015a)) and yeast (3.3 Å 
(Desai et al., 2017)). 
 
 
Figure 6 Structure of the human mitochondrial ribosome in two different orientations. 
Taken from (Amunts et al., 2015). 
One of the most striking differences in the mitochondrial ribosome compared 
to its bacterial ancestor is the loss of the 5S rRNA (Nierlich, 1982). The 5S 
rRNA is a conserved architectural feature of both the bacterial, archaeal and 
eukaryotic ribosome and acts as a structural scaffold for the formation of the 
central protuberance (CP) with ribosomal proteins (Voorhees et al., 2009). 
The CP is characterized as an area of the large ribosomal subunit that carries 
out important functions, like the mediation of intersubunit contacts to the small 
subunit for movement coordination during translation and for interaction with 
tRNAs in the intersubunit space (Dinman, 2005). Despite the missing 5S 
rRNA, the CP still exist within the mitochondrial ribosome, which raises the 
question about its organization (Amunts et al., 2015). The answer to this 
phenomenon was provided by cryoEM generated structural data, which 
showed a structural tRNA in the mammalian CP at a position similar to one 5S 
rRNA domain in bacteria (Greber et al., 2014;Brown et al., 2014). This tRNA 
was identified to be tRNAPhe in porcine mitochondria (Greber et al., 2014) and 
tRNAVal in human mitochondria (Brown et al., 2014).Both tRNAs flank the 12S 




rRNA (Figure 4). Similar to the 5S rRNA, the structural tRNA also interacts 
with mitochondrial ribosomal proteins in the CP, especially with a 
mitochondrial ribosomal protein in the large subunit, uL18m (Figure 7). 
Notably, there is a preserved interaction of the bacterial homolog uL18 with 
the 5S rRNA (Greber and Ban, 2016). Interestingly, the 5S rRNA is not 
replaced by a structural tRNA in yeast, but with an expansion of already 
existing rRNA(Amunts et al., 2014). 
 
 
Figure 7 Structure of the central protuberance of the human mitochondrial ribosome. 
Taken from (Brown et al., 2014). 
A second distinct structural adaption of the mitochondrial ribosome is the 
polypeptide exit tunnel (Figure 8). This tunnel is the path along which nascent 
chains pass in order to be released from the ribosome. Folding of the 
polypeptide chain may already take place during this process. Unlike 
eukaryotic or bacterial ribosomes, which have to adapt to a wide range of 
different proteins, the mitochondrial ribosome evolved to adapt for the 
synthesis of membrane proteins, to which all mitochondrial-translated proteins 
belong. The evolution of the exit tunnel was facilitated because the former 
rRNA structures in bacteria were exchanged for mitochondrial ribosomal 
proteins, which have the added ability to establish new properties for the 
surface of the exit tunnel. Indeed, the protein residues facing the surface of 
the mitochondrial ribosomal exit tunnel are of hydrophobic nature and show 
specific interactions with the nascent chain, thereby mimicking the native, 
hydrophobic environment of membranes(Brown et al., 2014). While the exit 
tunnel of the human mitochondrial ribosome still shows similarity to its 




ribosomes has completely changed position and is localized 3.5 nm away 
from its position in bacterial ribosomes.This relocalization is attributed to 2 
structural changes in the yeast mitochondrial ribosome; loss of helix 24 of the 
18S rRNA, which creates a new passage for the nascent chain into the 
solvent; and extension of the mitochondrial ribosomal protein uL23, which 
blocks the conserved path in the ribosome (Amunts et al., 2014). A further 
characteristic feature of the mitochondrial ribosome is located at the end of 
the exit tunnel. A mitochondrial ribosomal protein present in mammals, mL45, 
possesses C-terminal helices that extend into the inner boundary membrane 
(Greber et al., 2014). By mediating the membrane association of the 
mitochondrial ribosome, mL45 plays a major role in facilitating the membrane 
insertion of mitochondrial ribosomal transcripts (Greber et al., 2014Englmeier; 
et al., 2017). Membrane association is a general crucial feature of 
mitochondrial ribosomes, which is emphasized by the existence of a yeast 
homolog of mL45, known as Mba1. Even though it is not permanently 
associated with the mitochondrial ribosome, Mba1 mediates the membrane 
association of translating mitochondrial ribosomes and plays a role as a 
mediator between the nascent chain and the insertion machinery of the inner 





Figure 8 The mitochondrial ribosomal exit tunnel. A) Localization of the exit tunnel. B) 
Structure of the exit tunnel. A) and B) taken from (Brown et al., 2014). 
 
Despite the broad spectrum of adaptations during the evolution of the 
mitochondrial ribosome, the catalytic core still consists of conserved rRNA, 
with only few mitochondrial-specific elements. Still, there are small variations 
within the A, P and E sites, which affect mitochondrial translation. Due to the 
sequence-length variations of the D- and T- stems of mitochondrial tRNA, 
mammalian mitochondrial ribosomes lack the elements to interact with those 
regions (Helm et al., 2000). The missing elements are uL25m and the rRNA 
helix H38 (A-site finger) in the A-site, and uL5m and H84 in the P-site (Brown 
et al., 2014). In the P-site, mitochondrial ribosomes posses a distinct 
structural element called the P-site finger, which originates from the CP and 
may serve to compensate for the loss of ribosome-tRNA interaction caused by 
the missing A-site finger (Greber et al., 2015a). The E-site of mitochondrial 
ribosomes is rather unmodified in comparison with its bacterial predecessor 
and displays a CCA binding pocket, which is conserved in both sequence and 




in the small mitochondrial 28S subunit (Koch et al., 2015). The key structural 
elements of the decoding site show the same interactions within the codon-
anticodon helix, suggesting a highly conserved mechanism between 
mitochondrial ribosomes and their bacterial ancestors (Greber et al., 2015a). 
 
1.2.4 Mitochondrial translation and translationregulators 
 
Translation is a universally conserved mechanism that occurs in all forms of 
life. The translational process can be summarized into 3 different steps; (a) 
initiation, where the ribosome locks onto the start codon of the mRNA; (b) 
elongation, where the peptide is formed by the addition of amino acids and (c) 
termination, where the polypeptide chain is released from the ribosome and 
the ribosome is subsequently recycled. Each of these steps is facilitated by 
specific translation factors and even though the translation factors in 
mitochondria often have homologues in bacteria, adaptation was necessary 
because of the changes in mitochondrial mRNA, ribosome and the genetic 
code. 
In bacteria, translation initiation is aided by 3 initiation factors (IF1, IF2, IF3) 
and the bacterial rRNA of the SSU interacts with the highly conserved Shine-
Dalgarno sequence on mRNA to recognize the start of translation (Gualerzi 
and Pon, 2015). Mammalian mitochondrial mRNAs do not posses this feature, 
or a 5’ cap structure, but the start codon is identified closest to the 5’ end 
(Zhang et al., 2015). A lacking secondary structure at the 5’ end of 
mitochondrial mRNA is believed to facilitate codon recognition (Jones et al., 
2008). Furthermore, only IF2 and IF3 have a known mitochondrial homologue, 
while IF1 is missing (Liao and Spremulli, 1990;Koc and Spremulli, 
2002;Cummings and Hershey, 1994). IF3 promotes dissociation of the 
mitochondrial ribosome and prevents association of the mitochondrial 
monosome. For translation initiation, GTP-bound IF2 assists in tRNAMet 
placement in the P side of the SSU, displacing IF3 and allowing the LSU to 
bind. The formation of the active monosome causes the hydrolysis of GTP 




The process of elongation is the most conserved of the mitochondrial 
translation steps. Elongation is accompanied by 3 elongation factors, all with 
bacterial homologues; EF-Tu, in complex with GTP, provides the 
mitochondrial ribosome with aminoacyl-tRNA; EF-Ts exchange the GDP 
bound with EF-Tu to GTP, after it is released by the ribosome; EF-G1 
functions as a catalyst in the coordinated movement of mRNA and tRNA 
during translocation (Schwartzbach and Spremulli, 1989;Bhargava et al., 
2004). Despite the conservation of the elongation process, bacterial 
elongation factors are not able to function with the mammalian mitochondrial 
ribosome (Eberly et al., 1985). 
In contrast to the elongation process, mitochondrial termination is not as well 
conserved from bacteria. While bacteria have three stop codons (UGA, UAA, 
UAG) (Korkmaz et al., 2014), mitochondria only utilize two (UAA, UAG), with 
UGA coding for tryptophan. These two stop codons are supplemented with 
two additional non canonical stop codons, AGA/AGG (Lind et al., 2013). The 
bacterial stop codons are recognized by two release factors (RF1, RF2) (Ray-
Soni et al., 2016), of which only RF1 has a mitochondrial homologue 
(mtRF1a) (Lee et al., 1987). However, mitochondria posses an additional 
release factor, ICT1, which is able to recognize the stop codons (Akabane et 
al., 2014). Interestingly, ICT1 functions as both as a subunit of the 
mitochondrial ribosome and, in its non bound form, as a release factor for 
mitochondrial translation (Richter et al., 2010). Furthermore, there are two 
stop codon-independent release factors (mtRF1, C12ORF65), which are 
suggested to assist in the recycling of stalled ribosomes (Huynen et al., 2012), 
(Antonicka et al., 2010). After the release of the translated protein, the 
ribosome recycling factor (RRF1) and a specific homologue of the EF-G: EF-
G2 associates with the monosome and cause its disassembly in the free small 
and large subunit(Tsuboi et al., 2009). The free mitochondrial ribosomal 
subunits are thus recycled and IF3 can associate with the small subunit again 
(Christian and Spremulli, 2009). The process of mitochondrial translation is 






Figure 9 Mitochondrial translation cycle. Simplified depiction of mitochondrial 
translation.E, P, A: tRNA binding sites. Modified after (Ott et al., 2015). 
 
Besides the factors that facilitate the different steps of mitochondrial 
translation, another set of translation regulators exist, which coordinates the 
translation of specific proteins in mitochondria. Most of these proteins interact 
with the mitochondrial ribosome and with the inner membrane. In yeast, these 
translation regulators promote mitochondrial translation of their target mRNA 
via interaction with mostly the 5’UTR of mRNA. By promoting translation, 
these proteins play a key role in the regulation of mitochondrial 
translation(Dennerlein et al., 2017). Such control mechanisms are very 
important for the assembly of the OXPHOS complexes, because of the dual 
genetic origins of their subunits, which must be coordinated to form mature 
complexes. Evidence of crosstalk in both directions between mitochondria 
and nucleus was provided recently by ribosome profiling analysis (Couvillion 
et al., 2016) and the uncovering of the mitochondrial compromised protein 
import response (Weidberg and Amon, 2018). Despite being investigated 




regulators and since human mitochondrial mRNA do not have 5’ UTR 
regions,the translation regulatory mechanisms are expected to differ from that 
of yeast. Studies on the translation of COX1 have provided some insight into 
the regulation of mitochondrial translation in human. 
 
1.2.4.1 COX1 translation in human mitochondria 
 
The first translational regulator discovered in human mitochondria was 
TACO1, which is involved in the synthesis of COX1. It was shown by 
Weraarpachai et al. that depletion of TACO1 leads to the specific decrease of 
COX1 translation (Weraarpachai et al., 2009). Furthermore, a recent study 
verified that TACO1 binds the mRNA of COX1 specifically and interacts with 
the mitochondrial ribosome. The mRNA binding domain of TACO1 belongs to 
one of the three domains of the DUF28 family, a group of putative proteins 
with unknown function (Richman et al., 2016). Until now, TACO1 remains the 
only known translation regulator with mRNA interaction in human 
mitochondria.  
Nevertheless, other proteins were characterized that play a role in COX1 
translation; MITRAC12 and C12ORF62, which bear similarities to the yeast 
assembly factors Coa3 and Cox14 respectively. First characterized in 
Drosophila as an essential protein for the functionality of complex IV (Peralta 
et al., 2012), MITRAC12 was shown to play a role in human mitochondria for 
COX1 synthesis and stability, in addition to assembly of complex IV (Mick et 
al., 2012). MITRAC12 and newly synthesized COX1 were shown to appear in 
an early assembly intermediate of complex IV assembly, termed MITRAC 
(Mitochondrial Translation Regulation Assembly intermediate of Cytochrome c 
oxidase). The study by Mick et al. also characterized C12ORF62, another 
MITRAC subunit, as a factor necessary for COX1 translation, which was first 
described by Weraarpachai et al. in the same year (Weraarpachai et al., 
2012). In a recent study, Richter-Dennerlein et al. it was shown that the 
MITRAC complex is a dynamic complex with changing composition, which 
interacts with the translating mitochondrial ribosome during COX1 synthesis. 




with the COX1 translating ribosome and was shown to copurify with nascent 
chains of COX1. Those nascent chains could accumulate with C12ORF62 if 
COX1 translation is disturbed by puromycin(Richter-Dennerlein et al., 2016). 
Furthermore, depletion of C12ORF62 reduces COX1 synthesis, suggesting its 
involvement in a regulatory feedback loop for COX1 translation (Mick et al., 
2012;Richter-Dennerlein et al., 2016). Therefore, C12ORF62 has a specific 
role in the regulation of COX1 translation and its assembly into complex IV. 
 
1.3 Biogenesis of the oxidative phosphorylation system 
 
Mitochondria possess a highly diverse proteome. To date, 1837 mitochondrial 
and mitochondrial associated proteins have been identified in human 
(Palmfeldt and Bross, 2017) and over 3300 (Morgenstern et al., 2017) in 
yeast. Many of these proteins do not act alone and are organized into large 
complexes to fulfil their function within the organelle (MICOS, pyruvate 
dehydrogenase, translocases). The biogenesis of the complexes of the 
mitochondrial oxidative phosphorylation system (OXPHOS) is a unique 
process. Unlike other protein complexes, which consist solely of cytosolic 
translated proteins, OXPHOS complexes consist of subunits translated within 
both the cytosol and the mitochondria. Therefore, the assembly of OXPHOS 
is a complex procedure, where protein synthesis and protein import/export to 
the inner mitochondrial membrane have to be coordinated (Figure 10). Protein 
transport into the different compartments of mitochondria is realized by 
several distinct machineries. Most of them serve the purpose of protein import 
from the cytosol. Mitochondrial synthesized proteins are exported from the 
matrix to the IM via a conserved pathway. Despite being studied in detail 
within yeast, not all elements of the translocation machineries are conserved 
in human, therefore, protein import systems are only partially understood for 





Figure 10 The mitochondrial complex IV contain subunits of dual origin. Complex IV like 
other OXHPOS components (I, III, V) have subunits of both cytosolic and mitochondrial 
translational origin. The insertion of mitochondrial-translated subunits depends on the OXA 
machinery, while the cytosolic synthesized subunits have to be imported by different 
pathways into mitochondria. 
 
Cytosolic proteins destined for mitochondrial import first arrive at the 
translocase of the outer membrane (TOM). This translocase is responsible for 
the import of proteins into the IMS, where they are distributed further by a 
number of different transport systems, depending on their destination 
(Wiedemann and Pfanner, 2017). In both yeast and human, the TOM complex 
consists of the pore-forming protein TOM40 (Shiota et al., 2015), the receptor 
proteins: TOM20 (Abe et al., 2000), TOM22 (Yamano et al., 2008) and 
TOM70 (Brix et al., 2000), and three small TOM proteins: TOM5, TOM6, 
TOM7 (Kato and Mihara, 2008), which play a role in TOM assembly and 
stability (Shiota et al., 2015). In human mitochondria, hydrophobic precursor 
proteins interact with a number of chaperones including; HSP90 (Altieri, 
2012), HSC70 (Zara et al., 2009), AIP (Shiota et al., 2015) and TOM34 




The most well investigated import mechanism, which is also used by most of 
the OXPHOS subunits, is the TIM23-mediated presequence pathway to the 
inner mitochondrial membrane and the matrix. The presequence pathway 
covers the import of approximately 60 % of proteins destined for the 
mitochondria (Vögtle et al., 2009). Presequence pathway substrates are 
characterized by a positively charged presequence, usually around 15 to 50 
amino acids in length, which forms an amphipathic α-helix with a positively 
charged and hydrophobic face (Roise et al., 1986). The presequence helix is 
recognised during protein import by receptors and components of the TOM, 
TIM23 and PAM machinery andthe membrane potential (ΔΨ) facilitate the 
import of proteins with these positively charged presequences(Schulz et al., 
2015). 
The dynamic complex responsible for protein import into the mitochondrial 
inner membrane and the mitochondrial matrix is the Translocase of the Inner 
Membrane 23 (TIM23) complex. The yeast core complex consists of the 
presequence receptor, Tim50, which interacts with the protein precursors 
coming from the TOM complex (Schulz et al., 2011); the channel forming 
protein Tim23 (Denkert et al., 2017); the regulatory subunit Tim21 (Chacinska 
et al., 2005;van der Laan et al., 2006); and Tim17, which stabilizes the 
structure of the TIM23 complex (Matta et al., 2017). In human, the core 
components of TIM23 are largely conserved, although there are some 
differences. TIM17 exist in 2 isoforms: TIM17A and TIM17B. Despite both 
being expressed ubiquitously, TIM17A is rapidly degraded during stress 
conditions, whereas TIM17B has a more stable role in protein import (Rainbolt 
et al., 2013;Sinha et al., 2014).  
Depending on the target of the substrate, the core TIM23 complex can 
associate with other proteins or complexes. Precursors of IM proteins contain 
a hydrophobic sorting signal (Botelho et al., 2011), which is supposed to be 
recognized by the small membrane protein assisting with their sorting, Mgr2 
(Ieva et al., 2014). The release of those precursor proteins into the IM is 
driven by ΔΨ (van der Laan et al., 2007), which is enhanced by the 
recruitment of complex III-IV supercomplexes by Tim21 in yeast (Wiedemann 
et al., 2007)(van der Laan et al., 2006). In human mitochondria, the 




enigmatic and TIM21 instead fulfils a shuttle function and is involved in 
transporting imported proteins to their assembly intermediates (Mick et al., 
2012). 
The ΔΨ is not enough to drive protein import into the mitochondrial matrix 
alone. For this process, the core TIM23 complex associates with the 
presequence translocase-associated motor (PAM), whose function is 
evolutionally conserved between yeast and human mitochondria (Kang et al., 
2017). The PAM complex consists of an ATP consuming chaperone as its 
core (mtHsp70 in yeast (Horst et al., 1997), mortalin in human (Yaguchi et al., 
2007)) and catalyses the import of precursor proteins into the mitochondrial 
matrix. 
Besides the presequence pathway, other import systems exist that suit the 
specific needs of substrates and target them to the appropriate mitochondrial 
compartment. The sorting and assembly machinery (SAM) serves to insert ß-
barrel proteins into the mitochondrial outer membrane (Klein et al., 2012) after 
import by the TOM complex (Jores et al., 2016). The mitochondrial inter 
membrane space assembly machinery (MIA), with its core enzymes, Mia40 
(human: hMIA40) and Erv1 (human: ALR), specifically traps proteins with 
characteristic cysteine motifs, like CX3C and CX9C,destined for the inner 
membrane space. Mia40interacts with them by the formation of disulfide 
bonds and catalyses the intramolecular disulfide bond formation of the target 
protein (Stojanovski et al., 2012). The carrier pathway, comprising of the 
TIM22 complex, imports hydrophobic, multitransmembrane domain proteins 
into the inner membrane. Substrates include components of different TIM 
machineries (Tim23, Tim22, Tim17) and mitochondrial carrier 
proteins(Rehling et al., 2004;Kang et al., 2016;Callegari et al., 2016). 
Another crucial system, which is responsible for the membrane insertion of 
mitochondrial translated proteins, is the oxidase assembly (OXA) translocase. 
The main component of this system is Oxa1, a protein highly conserved from 
its bacterial ancestor, the YidC protein insertase, and was shown to export the 
mitochondrial translated proteins into the inner membrane in yeast (Hell et al., 
2001). Furthermore, Oxa1 is involved in “conservative sorting” processes, 
where proteins imported by the presequence pathway into the mitochondrial 




2013). The human homologueto Oxa1 is OXA1L and was shown to be able to 
substitute for Oxa1 in yeast (Bonnefoy et al., 1994). Nevertheless, it was 
reported byStiburek et al., that a knockdown of OXA1L only affect complex I 
and V, while complex III and IV are not affected (Stiburek et al., 2007). Hence 
the in detail function of OXA1L in human mitochondria needs to be further 
investigated.  
 
1.3.1 Biogenesis of the NADH Coenzyme Q oxidoreductase 
 
The NADH Coenzyme Q oxidoreductase, also called mitochondrial complex I, 
is the largest of all OXPHOS complexes, with a size over 1 MDa. Complex I is 
the entry site of electrons provided by the citric cycle in the form of NADH 
(Wikström, 1984).  The complex catalyzes the transfer of 2 electrons from 
NADH to ubiquinone and uses the chemical energy from that process to 
relocate 4 protons from the IMS to the mitochondrial matrix (Galkin et al., 
1999). The structure of complex I (Figure 11)has an L-shaped architecture, 
which can be divided into a membrane arm and a peripheral arm (Agip et al., 
2018;Fiedorczuk et al., 2016). The iron sulphur clusters are localized in the 
peripheral arm, which consists of the N and Q module (Agip et al., 
2018;Fiedorczuk et al., 2016). While the N module is responsible for oxidising 
NADH, the Q module handles the transfer of electrons to ubiquinone (Wirth et 
al., 2016). The reaction in the matrix arm induces conformational changes in 
the membrane arm, causing the translocation of protons via a still enigmatic 
mechanism. It has been proposed that the lateral α-helix of ND5, which lies 
planar to the membrane and reaches close to the ubiquinone binding site, 
plays a role in coupling the reduction of ubiquinone with the conformational 
change (Angerer et al., 2011). The membrane arm, consisting of the PP and 
the PD module, incorporates 4 proton channels, which consist of 
mitochondrial-translated subunits (Fiedorczuk et al., 2016). Mammalian 
complex I is composed of 45 subunits, 14 of which are core subunits, which 
are essential for the catalytic function and highly conserved from their 
bacterial ancestors. The accessory subunits of complex I bind peripherally to 
the conserved core in a cage-like structure (Sazanov et al., 2000). All the 
  
 
mitochondrial translated components of complex I belong to the group of core 
subunits (Vinothkumar et al., 2014
 
Figure 11Structure of the mouse mitochondrial complex I. 
The positions of the Fe-S clusters are highlighted separately.
The assembly of the mitochondrial complex I was characterized as a modular 
process by several groups 
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first into intermediate complexes, which are then further assembled into the 
mature complex. While the N and Q module assemble as distinct 
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The N module assembles around the three core subunits; NDUFS1, NDUFV1 
and NDUFV2 (Berrisford and Sazanov, 2009). Even though there is no 
experimental evidence of a stable assembly intermediate containing all N 
module subunits, an intermediate complex with the three core subunits of the 
N module was characterized in a knockdown of TIMMDC1, an assembly 
factor of the PP-a module (Guarani et al., 2014). The assembly of the N 
module is possibly assisted by NDUFAF2 and NUBPL. NDUFAF2 occurred 
from a duplication event of the accessory N module subunit NDUFA12 
(Ogilvie et al., 2005), and was shown to be able to interact with the N module 
at the position of NDUFA12, even though it cannot replace NDUFA12 to form 
a functional complex (Ostergaard et al., 2011). NDUFAF2 is not present in 
mature complex I, but it can interact with a stable assembly intermediate of 
complex I and with all modules except for the N module (Lazarou et al., 
2007;Vogel et al., 2007d). NUBPL is a putative assembly factor of the N 
module, which is believed to be involved in the incorporation of Fe-S clusters 
(Sheftel et al., 2009) and acts in the early assembly of the N module (Kevelam 
et al., 2013). NUBPL harbours a conserved cysteine motif (CXXC), enabling 
the binding of Fe-S clusters (Bych et al., 2008). Patients with mutations in the 
NUBPL gene were shown to have complex I deficiency (Sheftel et al., 2009). 
The Q module is formed around four core subunits; NDUFS2, NDUFS3, 
NDUFS7 and NDUFS8 (Brandt, 2006). In a first assembly step, NDUFS2 and 
NDUFS3 form a complex with the accessory subunit NDUFA5, followed by 
the addition of the Fe-S cluster containing proteins, NDUFS7 and NDUFS8 
(Guerrero-Castillo et al., 2017). The assembly factors NDUFAF3 and 
NDUFAF4 then join the still soluble assembly intermediate (Saada et al., 
2009;Guerrero-Castillo et al., 2017). Two other assembly factors acting in the 
assembly of the Q module are NDUFAF5 and NDUFAF7. NDUFAF5 
mutations were discovered in patients with complex I deficiency (Sugiana et 
al., 2008) and the assembly factor was characterized as an arginine 
hydroxylase, which adds a hydroxyl group at Arg-73 of the accessory Q 
module subunit, NDUFS7 (Rhein et al., 2016). NDUFAF7 interacts with the 
core subunit of the Q module, NDUFS2 (Carilla-Latorre et al., 2010), and is a 




NDUFS2 (Rhein et al., 2013). Furthermore, it has been proposed that NUBPL 
plays a role in the incorporation of Fe-S clusters. 
The assembly of the PP module is divided into the assembly of PP-a and PP-b. 
Interestingly, these two subassembly intermediates do not join directly after 
their assembly but associate with other modules(Guerrero-Castillo et al., 
2017). PP-a, together with the core subunit ND1, assembles onto the mature 
Q module and serves as an anchor to recruit it to the inner 
membrane(Sánchez-Caballero et al., 2016). This process is assisted by the Q 
module assembly factors, NDUFAF3 and NDUFAF4 (Andrews et al., 
2013),and by the PP-a module assembly factor of the TIM17/22/23 family, 
TMMCD1(Guarani et al., 2014), which are believed to prevent degradation of 
the complex by proteases(Zurita Rendon and Shoubridge, 2012). 
Furthermore, NDUFAF5, NDUFAF6 and NDUFAF7 were reported to have an 
effect on the translation of ND1.It was observed in cells with NDUFAF5 and 
NDUFAF6 mutations, or NDUFAF7 depletion, that the translation of ND1 is 
reduced(Sugiana et al., 2008;Zurita Rendón et al., 2014). Nevertheless, a 
direct interaction between NDUFAF5 and NDUFAF6 with newly synthesized 
ND1 or ND1 mRNA was never detected.This brings into question their role as 
translation regulators of ND1. 
Unlike the PP-a module, the PP-b module, with its core subunit ND2, 
assembles independently of other subcomplexes (Guerrero-Castillo et al., 
2017). It was shown by Guerrero Castillo et al. that the earliest PP-b module 
assembly intermediate consist of the core subunits ND2, the accessory 
subunits, NDUFC1 and NDUFC2, and the assembly factors ACAD9, 
MITRAC15 (COA1), ECSIT and NDUFAF1(Guerrero-Castillo et al., 
2017)Later, the core subunit ND3 joins the complex, with the assembly factors 
TMEM126B and TMEM186, followed by two additional core subunits, ND4L 
and ND6. It has also been reported that the PP-b module assembly factors, 
ACAD9, ECSIT, NDUFAF1, TMEM126B and the PP-a module assembly 
factor, TMMCD1, form a complex before interacting with complex I subunits 
(Giachin et al., 2016). The complex is called the mitochondrial complex I 
assembly (MCIA) complex.  
NDUFAF1 was shown to interact with complex I subunits of both 




depletion of NDUFAF1 led to a decrease in complex I activity (Vogel et al., 
2005). Therefore, NDUFAF1 is believed to carry out chaperone functions, 
while interacting transiently with proteins of the PP-b module, however, the 
mechanism is still enigmatic (Vogel et al., 2007c). ECSIT (Evolutionarily 
conserved signalling intermediate in Toll pathway) was first identified as a 
cytosolic adaptor protein, participating in the Toll pathway (Kopp et al., 1999). 
It was later shown to posses an N-terminal MTS of 48 amino acids that can 
direct the protein to mitochondria (Vogel et al., 2007b). Furthermore, cells with 
a knockout of ECSIT have reduced NDUFAF1 levels, which lead to a 
decrease in complex I activity (Vogel et al., 2007b). Interestingly, even though 
both NDUFAF1 and ECSIT posses the putative RNA binding motifs, RNA 
recognition motif (RRM) and pentatricopeptide repeat motif (PPR) 
respectively, no RNA interaction was ever detected for those proteins 
(Marchler-Bauer et al., 2014;Giachin et al., 2016). 
Similar to ECSIT, ACAD9 (Acyl-CoA dehydrogenase 9) was also first believed 
to carry out a function unrelated to OXPHOS assembly, because it belongs to 
the ACAD family, a group of flavoenzymes that catalyze the rate-limiting step 
of fatty acid β-oxidation (He et al., 2007).  Later, it was shown that a 
knockdown of ACAD9 impairs the assembly of complex I and also causes 
reduced levels of NDUFAF1 and ECSIT (Nouws et al., 2010). Interestingly, it 
was shown that a catalytically inactive mutant of ACAD9 was able to perform 
its function as an assembly factor (Nouws et al., 2013;Schiff et al., 2015). This 
information suggests that ACAD9 might fulfil two distinct roles as complex I 
assembly factor and in fatty acid β-oxidation.  
TMEM126B belongs to the TIM17/22/23 family, like the Q module assembly 
factor, TMMCD1 (Andrews et al., 2013). Being a membrane protein, it was 
suggested that TMEM126B coordinates the membrane association of the 
soluble proteins in the MCIA complex, which is supported by the observation 
that NDUFAF1, ECSIT, and ACAD9 are not recruited to the mitochondria IM if 
TMEM126B is depleted (Vartak et al., 2014). The connection between 
MITRAC15 and complex I was first reported by Mick et al., where MITRAC15 
was described as an assembly factor acting in the assembly pathways of both 
complex I and IV (Mick et al., 2012). In a more recent publication by Guerrero 




b module(Guerrero-Castillo et al., 2017). However, its function still needs to 
be investigated. 
The PD module also assembles in two distinct intermediates (PD-a, PD-b) 
(Guerrero-Castillo et al., 2017). In the case of the PD-a module, assembly 
starts with the nuclear encoded accessory subunits NDUFB5, NDUFB10 
andNDUFB11, which form the first assembly intermediate. NDUFB6 then joins 
in a following step (Guarani et al., 2014). NDUFB1 and the mitochondrial-
synthesized core subunit, ND4, are then added in a final step (Guerrero-
Castillo et al., 2017). The PD-a assembly intermediate coassociates with three 
assembly factors,FOXRED1, ATP5SL and DMAC1,all of which have 
uncharacterized functions(Guerrero-Castillo et al., 2017). While it is 
suggested that FOXRED1 acts in the late assembly of complex I (Formosa et 
al., 2015), ATP5SL and DMAC1 were reported to interact with newly 
synthesized, unassembled, ND5, as well as OXA1L, suggesting a role as 
translation regulators(Stroud et al., 2016). For the PD-b module, it’s assembly 
still remains enigmatic and no subassembly intermediates have been 
detected. 
The first assembly steps of complex I lead to the formation of 5 distinct 
intermediates (N module, Q-PP-a module, PP-b module, PD-a and PD-b 
module), which all have to be joined together to form the mature complex I. 
The traditional model proposes that the first step is the assembly of the PP-b 
and PD-a module to form the PP-b/PD-a intermediate(Guarani et al., 
2014;Perales-Clemente et al., 2010). During this assembly step, NDUFS5, 
NDUFA10 and NDUFB4 are incorporated into the PP-b/PD-a 
intermediate(Guerrero-Castillo et al., 2017). In the following step, both the Q-
PP-a module and the PD-b module assembles onto the PP-b/PD-a 
intermediate, forming the Q/P assembly intermediate(Vogel et al., 2007a), 
which is possibly accompanied by the incorporation of NDUFA9and the 
assembly factor NDUFAF2(Sánchez-Caballero et al., 2016). Nevertheless, it 
was shown in the mass spectrometry analysis of complex I assembly 
intermediates on BN gels by Guerrero Castillo et al., that the PP-b module can 
assembly with the Q-PP-a module directly, while the PD-a module assembles 
onto that intermediate (Guerrero-Castillo et al., 2017). This observation 




final steps include the addition of the N module, which is assisted by 
NDUFAF2 and the removal of the assembly factors(Schlehe et al., 2013). 
During the final assembly steps, NDUFS6 and the NDUFAF2 homologue, 
NDUFA12 are added to the complex, forming a mature complex I(Kmita et al., 






Figure 12 Modular assembly of the mitochondrial complex I. Mitochondrial translated 
subunits are marked with a red border. “NDUF” was left out of the name of complex I 
subunits. The assembly factors of complex I are shown in brown and the names were not 





1.3.2 Biogenesis of the cytochrome c oxidase 
 
The cytochrome c oxidase, or mitochondrial complex IV, is the last enzymatic 
complex within the electron transport chain. After cytochrome c is reduced by 
complex III, complex IV oxidize cytochrome c and transfers the electrons to 
oxygen, reducing it to water(Wikström and Sharma, 2018). For the reduction 
of each O2 molecule, four electrons has to be provided by two molecules of 
reduced cytochrome c, while four protons are consumed for the reaction of O2 
to twomolecules of H2O. During this process, four additional protons are 
transferred from the mitochondrial matrix into the IMS (Wikström et al., 2017). 
The cytochrome c oxidase belongs to the Type A1 heme-copper oxidases, 
which are characterized by an active site (binuclear center / BNC)(Figure 
13B), harbouring a heme a3. The catalytic core of complex IV consists of three 
highly hydrophobic mitochondrial translated subunits, COX1, COX2 and 
COX3(Michel et al., 1998) (Figure 13A). Electrons provided by reduced 
cytochrome c arrive first in the CuA centre, localized in COX2(Brändén et al., 
2002). The CuA centre then transfers the electrons to the heme a molecule in 
COX1, which then delivers it to the BNC(Kaila et al., 2010). The BNC consists 
of heme a3and a CuB centre The CuB centre is comprised of a copper ion with 
3 histidine ligands and a tyrosine residue linked to one of the 
histidines(Wikström et al., 2017). The BNC transfers the electrons to O2, 
which is bound by heme a3,and finishes the chemical reaction(Gorbikova et 
al., 2008). During this electron transfer, protons are transferred to the IMS by 
a proton pump with a proton-loading site, whose exact position could not be 
determined until now(Wikström and Sharma, 2018). Unlike COX1 or COX2, 
COX3 does not actively participate in the catalytic process but stabilizes the 






Figure 13 Structure of the cytochrome c oxidase. A) Structure of the cytochrome c 
oxidase. The mitochondrial translated core subunits COX1, COX2 and COX3 are 
highlightened and shown in blue, red and green respectively, while the cytosolic translated 
accessory subunits are shown in white. The chemical reaction catalysed by the complex is 
simplified. Taken from (Wikström et al., 2017). B) Binuclear center of complex IV. Taken from 
(Wikström and Sharma, 2018). 
 
The assembly of the mitochondrial complex IV is a highly complex process, 
partially due to the specific cofactors needed in this complex. Three Core 
subunits and 11 accessory subunits are assembled by more than 30 known 
assembly factors(Timón-Gómez et al., 2018). Even though the assembly of 
the cytochrome c oxidase was initially perceived to be linear (Wielburski and 
Nelson, 1983), recent studies in yeast and human mitochondrianow favour a 
modular process(Timón-Gómez et al., 2018;Vidoni et al., 2017;Aich et al., 
2018). COX1 and COX2 where shown to be processed individually, before 
forming subassembly intermediates and joining in the formation of the mature 
complex IV(Vidoni et al., 2017). Nevertheless, processing of COX3 and the 
late stage assembly of complex IV still remains enigmatic. 
 
1.3.2.1 Processing and assembly of COX1 
1.3.2.1.a COX1 translation and early assembly factors 
With 12 transmembrane domains and a size of 57 kDa, COX1 is the largest 
subunit of complex IV and contain three of its four metal centres (Michel et al., 
1998). The synthesis of COX1 is regulated by three known factors; TACO1, 




which is crucial for COX1 translation and association with the COX1 
translating ribosome; and, to a lesser extent, MITRAC12 (Richter-Dennerlein 
et al., 2016), which also associates with the COX1 translating ribosome, but 
plays more of a role in stabilizing synthesized COX1 (Mick et al., 2012). The 
first assembly intermediate with which COX1 associates, was termed 
MITRAC (Mick et al., 2012). The early stages of MITRAC already begin to 
assemble during the synthesis of COX1, with C12ORF62 being the earliest 
identified MITRAC subunit, followed by MITRAC12 (Richter-Dennerlein et al., 
2016). After the termination of COX1 translation and disassociation from the 
mitochondrial ribosome, MITRAC is visible in a range between 140 and 200 
kDa on BN-PAGE and contains COX4I-1, one of the first cytosolic 
synthesized complex IV subunits to join the complex (Mick et al., 2012). 
Bourens et al. characterized the protein CMC1, a twin CX9C motif containing 
protein that acts in complex IV assembly and comigrates with MITRAC on BN-
PAGE. However, CMC1 does not influence the synthesis of COX1 (Bourens 
and Barrientos, 2017a). CMC1 interacts with COX1, MITRAC12 and 
C12ORF62, but not with COX4I-1 (Bourens and Barrientos, 2017a). This 
argues that CMC1 only associates with MITRAC for a short period before 
COX4I-1 joins the complex. Furthermore, Vidoni et al. (Vidoni et al., 2017) 
detected a low molecular weight complex consisting of COX4I-1, COX5A and 
HIG1A by SILAC analysis from a BN-PAGE of DDM solubilized mitoplasts. 
HIG1A was characterized as an assembly factor for complex IV and it was 
suggested that COX4I-1 and COX5A assemble from this complex into 
MITRAC, while losing HIG1A (Vidoni et al., 2017).  
1.3.2.1.b The TIM21 shuttle and late MITRAC 
The MITRAC complex also interacts with the TIM23 translocase subunit, 
TIM21. In yeast, TIM21 promotes the interaction of the TIM23 complex with 
the TOM machinery and counteracts its interaction with the PAM complex, 
However, TIM21 fulfils a different function in human mitochondria. Mick et al. 
showed that the association of TIM21 can shift either towards MITRAC, or to 
the TIM23 complex, depending on whether cellular or mitochondrial 
translation is inhibited respectively. Furthermore, TIM21 is needed for the 




al., 2012).Based on these findings, a shuttle function was assigned to TIM21, 
implicating it in the transport of imported proteins from the translocase to 
MITRAC for further assembly. Additionally MITRAC15 was characterized as 
an assembly factor, which acts in both complex I and complex IV assembly 
and interacts with subunits of both complexes (Mick et al., 2012). In a more 
recent publication, MITRAC7 was characterized by Dennerlein at al. The 
interaction between MITRAC7 and COX1 was reduced in cells lacking 
complex IV (specifically the nuclear-encoded subunits COX4I-1 or COX6C), 
or TIM21, while the interaction between MITRAC12 and COX1 remained 
stable in those cells. Therefore, MITRAC7 was expected to act in the late 
stages of MITRAC (Dennerlein et al., 2015).Figure 14 summarized the 
present model of COX1 assembly in the MITRAC complex. 
 
 
Figure 14 Assembly of the MITRAC complex. The MITRAC complex assembles during 
COX1 translation and coordinates the assembly of the COX1 module. TIM21 shuttles 
between TIM23 and MITRAC. 
1.3.2.1.c Heme insertion into COX1 
A crucial step in providing two heme A molecules for the heme a and heme a3 
centres of COX1 is the biosynthesis of heme A from heme B. The conversion 
is performed by two enzymes, which are integrated in the inner mitochondrial 
membrane, COX10 and COX15 (Soto et al., 2012;Antonicka, 2003;Antonicka 
et al., 2003). While this process remains enigmatic for mitochondria in human, 
some information exists for the mechanism of heme A insertion into Cox1 in 
yeast. Cox10 (Khalimonchuk et al., 2012) and Cox15 (Swenson et al., 2016)  
were shown to oligomerize in yeast mitochondria and the oligomerization of 
Cox15 was proven to be crucial for both heme A biogenesis and insertion into 




its interaction with Pet117 (Taylor et al., 2017). PET117 in human was 
characterized as a late assembly factor for complex IV (Vidoni et al., 2017), 
but its role in heme A insertion has yet to be investigated. In human 
mitochondria, heme A insertion is suggested to take place in the later steps of 
complex IV assembly, since the formation of MITRAC was shown to be 
independent of COX10 (Bourens and Barrientos, 2017a). 
1.3.2.1.d Copper insertion into COX1 
Unlike the maturation of the heme centers in COX1, more information is 
available on copper insertion into the CuB site. For both the CuB site in 
COX1,as well as the CuA site in COX2, copper ions are provided by 
COX17(Oswald et al., 2009). COX17 is a conserved protein localized in the 
mitochondrial IMS and contains two hydrophobic CX9C motifs(Glerum et al., 
1996). Copper is bound by COX17 with a CCxC Cu(I) binding motif and even 
though COX17 is able to bind multipleCu(I) ions in its fully reduced 
state(Beers et al., 1997), it is believed to only transport one Cu(I) ion at a 
time(Banci et al., 2008). For copper delivery to the CuB site of COX1, the Cu(I) 
ion provided by COX17 is received by the copper chaperone COX11(Hiser et 
al., 2000). COX11 consists of a C-terminal soluble domain located in the IMS, 
which is coupled to an α-helical membrane anchor by a flexible linker of 15 
amino acids(Banci et al., 2004). The soluble domain of COX11 harbours a 
conserved CFCF motif and it was shown in yeast that both cysteines are 
important for copper binding and that COX11 forms a dimer with its soluble 
domain, in order to bind one Cu(I) ion with each monomer(Hüttemann et al., 
2001;Carr et al., 2002). The current model in yeast states that the soluble 
domains of the COX11 dimer are positioned above COX1 and the Cu(I) ion is 
transferred to the histidines of the CuB site, with the help of a reduced Cys-
111 in COX1(van Dijk et al., 2007;Thompson et al., 2010). This model is 
supported by the essentiality of COX19 for complex IV assembly, which is a 
twin CX9C protein that keeps Cys-111 in a reduced state(Bode et al., 2015). 
In human, COX11 and its ability to bind copper are well conserved(Banci et 
al., 2004). However, in COX19, the highly conserved dipeptide Tyr-Leu, which 
is crucial for its structure in yeast, is exchanged by Phe-Met in human 




and steric hindrance, which was a crucial feature in Tyr-Leu. Therefore, it is 
likely that CuB maturation is similar in yeast and human. 
 
1.3.2.2 Processing and assembly of COX2 
1.3.2.2.a COX2 membrane insertion and early assembly factors 
COX2 consists of a C-terminal globular domain localized in the IMS, which 
harbours the CuA centre, with two copper ions, and two N-terminal 
transmembrane helices anchored in the IM (Soto et al., 2012). In Yeast, Cox2 
translation is assisted by the translation factor Pet111 (Green-Willms et al., 
2001), which promotes the synthesis of the precursor protein, pCox2 (Lorenzi 
et al., 2016). The first N-terminal transmembrane helix is inserted into the 
inner mitochondrial membrane by Oxa1 (Bonnefoy et al., 2009), while Mba1 
(the yeast homologue of mL45) mediates the membrane association of the 
mitochondrial ribosome during translation (Lorenzi et al., 2016). Mba1 then 
shuttles pCox2 to Cox20, a Cox2 chaperone whose interaction with pCox2 
promotes the cleavage of the N-terminal extension of pCox2 by the inner 
membrane peptidase complex that comprises of Imp1, Imp2 and Som1 (Jan 
et al., 2000). After N-terminal cleavage, the membrane proteins Cox18, Mss2 
and Pnt1 promote the translocation of the C-terminal globular domain and the 
insertion of the second transmembrane helix into the IM (Bonnefoy et al., 
2009;Saracco and Fox, 2002). Interestingly, Cox18 resembles the Oxa1 
family of insertases, but its functionality is specific for Cox2 (Bonnefoy et al., 
2009). In human, the there is no N-terminal processing of COX2, also the 
human Oxa1 homologue, OXA1L, is not mandatory for the assembly of 
complexes III and IV (Stiburek et al., 2007), suggesting that other proteins can 
functionally substitute this translocase. Nevertheless, COX20 and COX18 are 
conserved from yeast to human and were shown to be crucial for the stability 
of COX2 and therefore further assembly of complex IV (Bourens et al., 
2014;Bourens and Barrientos, 2017b). Additionally, human COX18 is 
responsible for the translocation of the C-terminal soluble domain of COX2 to 
the IMS, like its yeast homologue (Bourens and Barrientos, 2017b), 




Lorenzi et al. characterized the human COX2 associated assembly factor 
TMEM177, which is not present in yeast. TMEM177 interact with COX2, 
SCO1, SCO2 and COX2, but not with COX18 and therefore associate with 
COX2 in its late stage maturation (Lorenzi et al., 2018). These data indict, that 
the maturation and assembly of COX2 into the mature mitochondrial complex 
IV has changed from yeast to human. 
1.3.2.2.b Copper insertion into COX2 
The CuAcentre of COX2 consists of two copper ions, bridged by the thiol side 
chains of two cysteine residues (Wikström et al., 2017). The reduced states of 
the thiol groups are crucial, since copper binding can be prevented by their 
oxidation (Timón-Gómez et al., 2018). Copper insertion into COX2 is 
coordinated by two assembly factors, SCO1 and SCO2 (Abriata et al., 2008). 
These copper chaperones posses a globular domain located in the 
mitochondrial IMS, which is tethered to the IM with a single α-helix (Banci et 
al., 2007a). They can bind one copper ion in both Cu(I) and Cu(II) oxidative 
state, with a CXXXC thioredoxin like motif (Banci et al., 2007a), which also 
allows them to reduce the cysteine residues in the CuA centre(Banci et al., 
2007b). Even though the two SCO proteins are closely related, they are both 
essential for CuA maturation and they cannot compensate for each other’s 
functions(Leary et al., 2009). The current model states that the SCO1 and 
SCO2 transfer the copper ions to the CuA centre, while reducing the cysteine 
residues(Timón-Gómez et al., 2018). After the copper transfer SCO1 is 
present in its reduced state and SCO2 in its oxidized state. SCO2 would then 
be reduced by SCO1 and both chaperones will be loaded with copper from 
COX17, preparing them for a new round of CuA maturation(Banci et al., 2008). 
In addition to copper transfer, COX17 also performs the reduction of oxidized 
SCO1 (Leary et al., 2009). Another assembly factor that assists in COX2 
maturation in human is COA6, a soluble protein in the IMS. Pacheu et al. 
showed that COA6 affects the stability of COX2 and specifically interacts with 
the copper chaperone, SCO2, suggesting a role in CuA maturation(Pacheu-






Figure 15 Maturation of COX2. 
 
1.3.2.3 Late stage assembly of the cytochrome c oxidase 
 
Very little is currently known about the later stages of complex IV assembly. A 
differentiation between late and early stage complex IV subunits in human 
was first attempted by Lazarou et al. (Lazarou et al., 2009), who characterized 
COX4I-1 as an early subunit and COX6A and COX7A as late subunits of the 
cytochrome c oxidase. Recently, Vidoni et al. (Vidoni et al., 2017) 
characterized complex IV assembly intermediates in WT mitochondria and 
mitochondria with a frameshift mutation in COX3 by BN PAGE and SILAC 
analysis. Their findings led to a preliminary assembly model for cytochrome c 
oxidase and they characterized the proteins MR1-S, PET117 and PET100 as 
late stage assembly factors. PET100 was found to mediate the interaction 
between PET117 and MR1-S and with complex IV subunits. Furthermore, 
Aich et al. (Aich et al., 2018) characterized COX16 and found it to mediate the 
interaction of the copper chaperone SCO1 with COX2. Interestingly, COX16 
also promotes assembly of COX2 with the COX1-containing late stage 
MITRAC complex, where MITRAC12 is still present, but C12ORF62 has 






Figure 16 Putative model for the cytochrome c oxidase assembly. Complex IV assembly 
works with the COX1 module as a core. After COX1 translation assisted by MITRAC12 and 
C12ORF62, COX1 transits into the early MITRAC complex with CMC1, MITRAC12, 
C12ORF62, SURF1, where the metal centres in COX1 mature with the assistance of COX10 
and COX15 for heme A and COX11 and COX19 for copper. The COX4I-1, COX5A and 
HIGD1A complex then provided the subunits COX4I-1 and COX5A, which assembles into 
MITRAC after the disassociation of CMC1. After the maturation of COX2 assisted by COX18, 
COX20, COA6, SCO1, SCO2 and COX16, COX16 promotes the assembly of the COX2 
module with COX6C, COX7B, COX7C and COX8A onto late stage MITRAC. This is followed 
by the assembly of the COX3 module to the complex with COX6A, COX6B and COX7A2. The 
last step of complex IV assembly is the addition of NDUFA4 and COX7A2L. Modified after 



















1.4 Aims of this study 
 
The mitochondrial ribosome is unique machinery, which differs both from its 
bacterial ancestor and the cellular ribosome. Coevolved together with the 
mitochondrial and cellular genome, the mitochondrial ribosome is specialized 
in the synthesis of a small number of highly hydrophobic proteins still encoded 
by the mitochondrial genome. The translation in mitochondria and in the 
cytosol have to be coordinated to optimize the assembly of the OXPHOS 
complexes, which mostly consist of subunits of both mitochondrial and 
cytosolic translational origin. In yeast, specific cytosolic translated translations 
regulators are often needed by the mitochondrial ribosome to translate the 
mitochondrial-encoded proteins. Some of the translation regulators also 
participate in the assembly of OXPHOS complexes and therefore regulates 
mitochondrial translation via a feedback loop mechanism. 
In human, little is known of translation regulators. One of the few 
characterized mitochondrial ribosome associated translations regulator is 
C12ORF62. This protein is essential for the translation of COX1 in human 
mitochondria and is also present in the MITRAC complex, which is an early 
assembly intermediate of the cytochrome c oxidase. In this thesis, a 
C12ORF62FLAG cell line should be used to purify an early form of the MITRAC 
complex, while it is still associated with the mitochondrial ribosome. To 
accomplish this, the crude mitochondrial ribosome fraction has to be isolated 
and the MITRAC associated mitochondrial ribosome should be obtained by 
FLAG immunopurification. 
MITRAC15 is a protein, which was detected in the MITRAC complex. It was 
shown to act in both complex IV and complex I assembly and is also present 
in an early assembly intermediate of the PP-b module. In this thesis, the 
function of MITRAC15 should be characterized further. Therefore, a 
MITRAC15FLAG cell line was created to investigate the interaction network of 







2 Materials and methods 
2.1 Materials 
2.1.1 Chemicals and enzymes 
 
Table 1 List of chemicals used in this study. 
Chemical Supplier 
[35S]-L-methionine Hartmann Analytic 
2-mercaptoethanol (β-mercaptoethanol) Sigma-Aldrich 
6-aminocaproic acid Sigma-Aldrich 
Acetic acid Roth 
Acetone AppliChem or Merk 
Acrylamide/bisacrylamide (37.5:1) solution 
(Rotiphorese® Gel 30) 
Roth 
Acrylamide, 4x crystallized Roth 
Adenine hemisulfate salt Sigma-Aldrich 
ADP (adenosine-5'-diphosphate) Sigma-Aldrich 
Agarose NEEO ultra-quality Roth 
Ammonium acetate (NH4Ac) Merck 
Ampicillin AppliChem 
Anisomycin Sigma-Aldrich 
Anti-FLAG M2 agarose beads Sigma-Aldrich 
Antimycin A Sigma-Aldrich 
ATP (adenosine-5'-triphosphate) Roche 
BactoTM Agar BD 
BactoTM Peptone BD 
BactoTM Tryptone BD 
Bacto Yeast Extract BD 





Bovine serum albumin (BSA) fatty acid free Sigma-Aldrich 
Bromophenol Blue Merck 
Calcium chloride(CaCl2) dihydrate Roth 
Chloramphenicol Roth 
cOmplete, EDTA-free protease inhibitor tablet Roche 
Coomassie Brilliant Blue G-250 Serva 
Coomassie Brilliant Blue R-250 Serva 
Creatine kinase Roche 
Creatine phosphate Roche 
Diaminobenzidine (DAB) Sigma-Aldrich 
DDM (n-Dodecyl-b-D-maltoside) Sigma-Aldrich 
DMNG (Decyl Maltose Neopentyl Glycol) Antrace 
Digitonin Calbiochem 
DMEM (Dulbecco's Modified Eagle Medium) Gibco 
DMP (dimethyl pimelimidate) Sigma-Aldrich 
DMSO (dimethylsulfoxide) AppliChem 
DNase I Roche 
DTT (1,4-dithiothreitol) Roth 
ECL Western Blotting detection reagent GE-Healthcare 
EDTA (ethylene diamine tetraacetic acid) Roth 
Emetine Sigma 
Ethanol Roth 
Ethidium bromide 0.07% AppliChem 
FastDigest Green Buffer (10X) Thermo Scientific 
FLAG Peptide Sigma-Aldrich 
Galactose, D(+) Roth 
GeneJuice Novogen 
GeneRuler DNA Ladder Mix Fermentas 
Glucose, D(+) Roth 










Herring sperm DNA Promega 
KOD Hot Start DNA Polymerase Novagen 
HMW calibration Kit GE-Healthcare 
Hydrochloric acid (HCl) 37% Roth 
Hydrogen peroxide solution Sigma-Aldrich 
Hygromycin B Invitrogen 
IgG from bovineserum Bio-Rad 
IgG from human serum Sigma-Aldrich 
Imidazole Merck 
IPTG(Isopropyl β-D-1-thiogalactopyranoside) Roth 
LMNG (Lauryl Maltose Neopentyl Glycol) Antrace 
Lithium acetate (LiAc) AppliChem 
Lipofectamine RNAiMAX Invitrogen 
Luminol Sigmal-Aldrich 
Lysozyme from chicken egg white Sigma-Aldrich 
Magnesium chloride (MgCl2) heptahydrate Merck 
Magnesium sulfate (MgSO4) heptahydrate Roth 
Manganese (II)chloride (MnCl2) tetrahydrate Roth 
Methanol Roth 
Milk powder Grano Vita 
MOPS (morpholinopropanesulfonic acid) Sigma-Aldrich 
NADH (nicotinamide adenine dinucleotide) Roche 
Ni-NTA agarose Qiagen 










Oxaloacetic acid Sigma-Aldrich 
Penicillin-Streptomycin (10,000 U/mL) Gibco 
PMSF (phenylmethanesulfonyluoride) Roth 
Potassium acetate (KAc) Merck 
Potassium chloride (KCl) Roth 
Potassium cyanide (KCN) Sigma-Aldrich 
Potassium dihydrogen phosphate (KH2PO4) Merck 




Potassium hydroxid (KOH) Roth 
cOmplete™ Protease Inhibitor Cocktail Tablets Roche 
Plus Protein™ All Blue Prestained Protein 
Standard was 
Bio-Rad 
Proteinase K Roche 
Protein-A Sepharose GE-Healthcare 
Puromycin Invivogen 
Roti-Quant® reagent Roth 
Rotiphorese® Gel 30 (37,5:1) Roth 
Rubidium chloride (RbCl) Roth 
Saccharose Roth 
SDS (sodium dodecyl sulfate) Serva 
SDS marker broad range Biorad 
Sodium azide Sigma-Aldrich 
Sodium chloride (NaCl) Roth 








Sodium bicarbonate (Na2CO3) Sigma-Aldrich 
Sodium hydrogen carbonate (NaHCO3) Merck 
di-Sodium hydrogen phosphate (Na2HPO4) AppliChem 
Sodium pyruvate 100x Sigma-Aldrich 
Sodium tetraborate Merck 
Sorbitol  Roth 
D(+)-Sucrose, RNase Free and DNase Free Roth 
Sulfuric acid (H2SO4) Merck 
TCA (trichloroacetic acid)  Merck 
Tetracycline Roth 
TEMED (tetramethylethylenediamine) Roth 
Trehalose Roth 
Tricine  Roth 
Tris (tris(hydroxymethyl)aminomethane) Roth 
Triton X-100 Sigma-Aldrich 
TRIzol Thermo Fisher 




USB® Taq DNA Polymerase Affymetrix 








2.1.2 Kits and disposals 
 
Table 2 List of Kits and disposals used in this study. 
Product Supplier 
Amicon® Ultra-4 centrifugal filter unit 
10K MWCO 
Millipore 
Blotting paper Heinemann Labortechnik 
Cell culture flasks 25 cm2, 75 cm2 Thermo Fisher 
Cell culture plates 6, 12, 24, 96 well Greiner 
CELLSTAR® single cell cultre plates Greiner 
CELLSTAR® Centrifuge Tubes  Greiner Bio-One 
Complex I Enzyme Activity Microplate 
Assay Kit 
abcam 
Complex I Enzyme Activity Microplate 
Assay Kit 
abcam 
Fast Digest restriction enzymes Fermentas 
Flexi® Rabbit Reticulocyte Lysate 
System 
Promega 
GeneRuler DNA Ladder Mix Fermentas 
High Pure PCR Template Preparation 
Kit 
Roche 
Immobilon-P Transfer membrane 
(PVDF) 
Millipore 
KOD Hot Start DNA Polymerase Merck 
MEDIX X-ray films FOMA BOHEMIA 
Microtube 1.5 ml and 2.0 ml Sarstedt 




Pipette tips 10 μl, 200 μl, and 1 ml Sarstedt 
QuickExtract™ DNA Extraction Solution Lucigen 
Rapid DNA Ligation Kit Thermo Scientific 
Resourse S column 5 ml GE Healthcare 
Spin columns Mobicol “classic” MoBiTec 
TnT® Quick Coupled 
Transcription/Translation System 
Promega 
Wizard® Plus SV Gel and PCR DNA 
Purification System 
Promega 




2.1.3 Buffers and solutions 
 
Table 3 List of buffers and solutions used in this study. 
Buffer/Solution Composition 
Acetate buffer 0.5 M NH4Ac/acetic acid pH 3.5  
Agarose gel solution 1% agarose, TAE buffer 
AVO mix 
1 mM antimycin, 0.1 mM valinomycin 
2 mM oligomycin 
Blocking solution 5%-10% milk powder in TBST 
Blotting buffer 
25 mM Tris, 192 mM glycine, 10% 
methanol 
BN acrylamide 48% acrylamide, 1.5% bis-acrylamide 
BN anode buffer 50 mM Bis-Tris/HCl pH 7.0 




BN blue cathode buffer 
50 mM tricine, 15 mM Bis-Tris, 0.2% 
Coomassie Brilliant Blue G-250 
BN gel buffer (3X) 
200 mM 6-aminocaproic acid, 150 mM 
Bis-Tris/HCl pH 7.0 
BN loading buffer (10X) 
5% Coomassie Brilliant Blue G-250, 
500 mM  
6-aminocaproic acid, 100 mM Bis-
Tris/HCl pH 7.0 
BN solubilization buffer 
(EDTA) 
20 mM Tris/HCl, 60 mM NaCl, 10% 
glycerol, 1 mM EDTA, 1mM PMSF with 
1% digitonin or 0.6% DDM 
BN solubilization buffer 
(MgCl2) 
20 mM Tris/HCl, 60 mM NaCl, 10% 
glycerol, 20 mM MgCl2, 1mM PMSF 
with 1% digitonin or 0.6% DDM 
Cell culture medium 
DMEM (Dulbecco’s Modified Eagle 
Medium) supplemented with 10% (v/v) 
fetal bovine serum, 1mM sodium 
pyruvate, 2 mM L-Glutamine, 50 μg/ml 




40% ethanol, 10% acetic acid 
Coomassie staining solution 
0.25% Coomassie Brilliant Blue R-250, 
40% ethanol, 10% acetic acid 
Digitonin stock solution 5% digitonin in H2O 
DNA loading dye 10% saccharose, 0.25% OrangeG 
DTT buffer 
10 mM DTT, 100 mM Tris/H2SO4 pH 
9.4 
Fast lysate buffer 
150 mM NaCl, 20 mM MgCl2, 1 mM 
PMSF, 50 mM Tris/HCl pH 7.4 with 1 % 
NP-40 Substitute, cOmplete™ 
Protease Inhibitor Cocktail Tablets 
1/50 ml 
Gel filtration buffer 
150 mM NaCl, 10 % glycerol, 20 mM 
MgCl2, 1 mM PMSF, 50 mM Tris/HCl 
pH 7.4 with 0.05 % PCC 
Homogenization buffer 
0.6 M sorbitol, 1 mM EDTA, 0.2% fatty 
acid free BSA, 1 mM PMSF, 10 mM 
Tris/HCl pH 7.4 
Hypotonic buffer (import) 
100 mM sucrose, 1 mM EGTA, 10 mM 




Hypertonic buffer (import) 1.25 M sucrose, 10 mM MOPS, pH 7.2 
Import buffer 
250 mM sucrose, 80 mM KAcO, 5 mM 
Mg(AcO)2, 5 mM methionine, 10 mM 
sodium succinate, 20 mM HEPES, pH 
7.4 
Isolation buffer (import) 
225 mM sucrose, 75 mM mannitol, 
1 mM EGTA, 10 mM MOPS, pH 7.2 
PMSF stock 0.2 M PMSF in ethanol 
Potassium phosphate (KPi) 
buffer  
80.2% K2HPO4, 19.8% KH2PO4 
Resolving gel (SDS PAGE) 
10-16% acrylamide (Rotiphorese® Gel 
30), 0.05% TEMED, 0.1% APS, 0.1% 
SDS, 386 mM Tris/HCl pH 8.8 
Resolving gel (Urea PAGE) 
17.5% acrylamide, 0.23% bis-
acrylamide,  
5.4 M urea, 8 mM NaCl, 0.09% SDS, 
0.1% APS, 0.05% TEMED,  
684 mM Tris/HCl pH 8.8 
RF1 buffer 
100 mM RbCl, 50 mM MnCl2, 30 mM 
sodium acetate, 15 mM CaCl2, 15 % 
glycerol, pH 5.8 
RF2 buffer 
10 mM RbCl, 50 mM MnCl2, 10 mM 
MOPS, 75 mM CaCl2, 15 % glycerol, 
pH 6.8 
SDS loading buffer 
10% glycerol, 2% SDS, 0.01% 
bromophenole blue, 1% β-
mercaptoethanol,  
60 mM Tris/HCl pH 6.8 
SDS running buffer 
25 mM Tris, 192 mM glycine, 0.1% 
SDS 
SEM buffer 
250 mM saccharose, 1 mM EDTA,  
10 mM MOPS/KOH pH 7.2 
Stacking gel (SDS PAGE) 
4% arylamide, 0.1% SDS, 0.1% APS,  
0.05% TEMED, 80 mM Tris/HCl pH 6.8 
Stacking gel (Urea PAGE) 
5.4% arylamide, 0.07% bis-acrylamide, 
0.12% SDS, 3.33 M urea, 0.1% APS,  




150 mM NaCl, 260 mM sucrose, 
20 mM MgCl2, 1 mM PMSF, 50 mM 






150 mM NaCl, 10% glycerol, 20 mM 
MgCl2, 1 mM PMSF, 50 mM Tris/HCl 
pH 7.4 with 1% digitonin or 0.5% PCC 
Sucrose cushion 
Sucrose 34 %, 150 mM NaCl, 20 mM 
MgCl2, 50 mM Tris/HCl pH 7.4, 0.1 % 
PCC, cOmplete™ Protease Inhibitor 
Cocktail Tablets 1/50 ml 
TAE buffer 
2 mM EDTA, 40 mM Tris/acetic acid pH 
8.0 
TBS (Tris-Buffered Saline) 150 mM NaCl, 50 mM Tris/HCl pH 7.5 
TBST (TBS and Tween-20) 
150 mM NaCl, 0.05% Tween-20,  
50 mM Tris/HCl pH 7.5 
TCA solution 100% TCA in water 
TE buffer 1 mM EDTA, 10 mM Tris/HCl pH 8.0 
TfB1 buffer 
30 mM KAc, 100 mM RbCl, 10 mM 
CaCl2,  
50 mM MnCl2, 15% glycerol/acetic acid 
pH 5.8 
TfB2 buffer 
10mM RbCl, 75 mM CaCl2, 15% 
glycerol,  
10 mM MOPS/KOH pH 6.5 
TH buffer 
300 mM Trehalose10 mM KCl, 10 mM 
HEPES, pH 7.4 
Urea PAGE acrylamide 
60 % acrylamide, 0.8 % bis-acrylamide 
in H2O 
Urea PAGE running buffer 




150 mM NaCl, 10 % glycerol, 20 mM 
MgCl2, 1 mM PMSF, 50 mM Tris/HCl 
pH 7.4 with 0.1 % digitonin or 0.05 % 
PCC 
Washing buffer (cryoEM) 
150 mM NaCl, 0.5 % glycerol, 20 mM 
MgCl2, 1 mM PMSF, 50 mM HEPES 










Primary polyclonal antibodies were cultivated in rabbit by the injection of 
synthetic peptides or purified proteins. Goat anti-rabbit coupled to 
horseradish-peroxidase (HRP) (Dianova) was used as secondary antibody for 
detection.  
 
2.1.5 Plasmids and Oligonucleotides 
 
Plasmids used in this work were enriched in competent Escherichia coli (E. 
coli) XL1-Blue cells (Stratagene). 
 
Table 4 List of plasmids used in this study. 
Plasmid Backbone Insert Source 
pX330 - - 
(Ann Ran et al., 
2013) 
pOTB7-COX6A1 pOTB7 COX6A1 (Mick et al., 2012) 
pcDNA5-NDUFB8 pcDNA5 NDUFB8 This study 
pEGFP-N1 - - Clonetech 
 
Primer and siRNA used in this study are listed in Table 5. DNA primers were 
synthesized by Microsynth Seqlab and siRNA were provided by Eurogentec. 
 
 
Table 5 Oligonnucleoties used in this study. 











































(Mick et al., 2012) 
HEK293-Flp-InTM T-RExTM (HEK239T)-
C12ORF62-FLAG 






2.1.7Equipment and software 
 
Table 7 List of Instruments used in this study. 
Instrument Manufacturer 
5417 R (centrifuge)  Eppendorf  
5424 (centrifuge)  Eppendorf  
5804 R (centrifuge)  Eppendorf  
Sorvall RC 6 Plus (centrifuge) Thermo Scientific  
JA-20 Rotor Beckman Coulter 




HiLoad 16/600 Superdex 200 pg 
(Column) 
GE Healthcare 
Superdex 200 10/300 GL (Column) GE Healthcare 
Curix 60 (developing machine)  AGFA  
EPS 601 power supply  GE Healthcare  
GeneAmp PCR Systeme 2700 (thermo 
cycler)  
Applied Biosystems  
Heraeus® Hera cell 150 (incubator)  Thermo Scientific  




Hoefer SE600 Ruby Blue native system  GE Healthcare  
Light microscope  Zeiss  
NanoVueTM Spectrophotometer  GE Healthcare  
Optima L-90K Ultracentrifuge Beckman Coulter 
SW 41 Ti Rotor Beckman Coulter 
Potter S (Dounce homogenizer)  Sartorius  
Semi Dry Blotting Chamber  
PEQLAB 
Biotechnologie  
Amersham Typhoon Gel and Blot 
Imaging Systems 
GE Healthcare  
Storage Phosphor screen  GE Healthcare  
Thermomixer comfort  Eppendorf  
Typhoon FLA 9500 Phosphoimager  GE Healthcare  
Universal 320 (centrifuge)  Hettich  







Table 8 Software used in this study. 
Software Producer 
Adobe Illustrator CS5 Adobe  
Adobe Photoshop CS5 Adobe  
Data Graph 3.1.1. Visual Data Tools  
Geneious R11 Biomatters  
ImageQuant TL GE Healthcare 
ChimeraX UCSF 
Papers 3 Mekentosj 
 
2.2Methods 
2.2.1 Cultivation of human cells 
 
HEK293-Flp-InTM T-RExTM (HEK239T) cell lines were cultured in DMEM 
supplemented as described in Table 3. Cell lines were cultivated at 37°C 
under a 5% CO2 humidified atmosphere and passaged upon reaching 
confluence. Cells were harvested using PBS with 1 mM EDTA and reseeded 
or harvested using PBS and processed afterwards or stored at -20 °C. 
 
2.2.2Generation of knockout cell lines using the CRISPR-Cas9 system 
2.2.2.1 Design of oligonucleotides 
The target within the gene of interest was selected using software provided by 
the lab of Feng Zhang(Hsu et al., 2013) (http://crispr.mit.edu/). And the top 
three results were used for the generation of knockouts. The selected guide 
sequenced were modified the following way for cloning into a pX330 vector 
(N=guide sequence, N=complement to guide sequence): 
5´- CACC (G) NNNNNNNNNNNNNNNNNNNN -3´ 




2.2.2.2 Cloning of oligonucleotides into the pX330 vector 
5 µl of each oligo (forward and reverse, 100 µM) were mixed with 30 µl of 
water and 10 µl of 5x ligation buffer from the Rapid DNA Ligation Kit 
(ThermoScientific). The mixture was heated 5 min at 95 °C and the 
temperature was decreased 5 °C/min until 20 °C. 1 µg of the pX330 vector 
were digested with 1μL BbsI (ThermoScientific) for 30 minutes and purified 
with the Wizard® Plus SV Gel and PCR DNA Purification System. 2 µl of the 
annealed oligonucleotide duplex was ligated with 50 ng of the cutted pX330 
vector and amplified in competent E. coliXL1-Blue cells (described in XXX).  
2.2.2.3 Transfection of HEK293T cells 
Cells were seeded in a 6 well plate 2 d before transfection. The confluence on 
the day of the transfection should be around 40 % in the plate. 100 μl Opti-
MEM, 5 μl Gene Juice, 2 μg of pX330 plasmids with guide and 400 ng 
enhanced GFP plasmid (pEGFP-N1; Clonetech Laboratories, Inc) were mixed 
and incubated 20 min at room temperature. 600 µl medium without penicillin 
and streptomycin was added to the mixture and it was transferred onto the 
cells after removal of media from the 6 well plate. After 3 h incubation at 
37 °C, 4 ml medium without penicillin and streptomycin was added to the 
cells. After 3 days, cells were harvested with and sorted. 
2.2.2.4 Cell sorting and expansion 
Three days after transfection, cells were harvested with PBS containing 1 mM 
EDTA. Cells were kept in PBS/1 mM EDTA at 37 °C until sorting. Cells were 
sorted using a FACS Vantage SE by Sabrina Becker (UMG Cell sorting 
facility). GFP positive cells were sorted into 96 well plates and after the single 
colonies grew to a sufficient size, they were transferred to a 24 well plate. 
Cells were analyzed by Western blotting and clones, which does not display 
the protein of interest were further analyzed by sequencing. Clones which 






2.2.3Labelling of newly synthesized mitochondrial proteins using [35S] 
methionine 
Protocolls for[35S] methioninelabelling of newly synthesized mitochondrial 
proteins are modified after (Jeffreys and Craig, 1976). 
2.2.3.1 Pulse labelling 
Cells were seeded in 25 cm2 flasks 3 d before labelling. Media was removed 
from cells and 2 ml FCS/methionine free media were added to the cells. After 
10 min incubation at 37 °C, the media was removed from the cells and 2 ml 
FCS/Met free media were added to the cells again. After another round of 10 
min incubationat 37 °C, the media was removed and 1,5 ml FCS containing 
methionine free media with 100 µg emetin /1 ml media was added to the cells. 
After 10 min incubation at 37 °C, 500 media was taken out of the flasks and 
20 µl [35S] methionine (Hartmann Analytic) was added to the media. After 1 h 
incubation at 37 °C, the media was removed and cells were harvested and 
wash twice with PBS. 
2.2.3.2 Pulse chase labelling 
Cells were seeded in 25 cm2 flasks 3 d before labelling. Media was removed 
from cells and 2 ml FCS/methionine free media were added to the cells. After 
10 min incubation at 37 °C, the media was removed from the cells and 2 ml 
FCS/Met free media were added to the cells again. After another round of 10 
min incubationat 37 °C, the media was removed and 1,5 ml FCS containing 
methionine free media with 100 µg anisomycin /1 ml media was added to the 
cells. After 10 min incubation at 37 °C, 500 media was taken out of the flasks 
and 20 µl [35S] methionine (Hartmann Analytic) was added to the media. After 
1 h incubation at 37 °C, the media was removed and 10 ml media with 
penicillin and streptomycin were added to the cells. After the chasing time, the 
media was removed and cells were harvested and wash twice with PBS. 
2.2.3.3 Pulse labelling with puromycin treatment 
Cells were seeded in 25 cm2 flasks 3 d before labelling. Media was removed 
from cells and 2 ml FCS/methionine free media were added to the cells. After 
10 min incubation at 37 °C, the media was removed from the cells and 2 ml 




min incubationat 37 °C, the media was removed and 1,5 ml FCS containing 
methionine free media with 100 µg emetin /1 ml media was added to the cells. 
After 10 min incubation at 37 °C, 500 media was taken out of the flasks and 
20 µl [35S] methionine (Hartmann Analytic) were added to the media. After 
10 min incubation at 37 °C,2 µg/ml puromycin was added to the media.After 
20 min incubation at 37 °C, the media was removed and cells were harvested 
and wash twice with PBS. 
 
2.2.4Isolation of human mitochondria 
Protocols of isolation of human mitochondria were modified after(Mick et al., 
2012) and protocol for isolation of human mitochondria for import was 
modified afterprotocolls from Alexander Panov (Panov,2013).  
2.2.4.1 Isolation of human mitochondria 
Cells were harvested in PBS and pelleted 15 min at 4700 rpm and 4 °C. Cell 
pellets were resuspended in TH buffer with 0.1 mg BSA/ml and pottered 30x 
at 800 rpm on ice. Centrifugation steps were carried out in reaction tubes with 
a 5417 R centrifuge (Eppendorf).  Cellular debris was pelleted 10 min at 400 g 
and 4 °C. The supernatant (SN1) containing mitochondria was collected. The 
cellular debris was resuspended in TH buffer with 0.1 mg BSA/ml and 
pottered again 30x at 800 rpm on ice and pelleted 10 min at 400 g and 4 °C. 
The pellet was discarded and the supernatant (SN2) was added to SN1 and 
pelleted 7 min at 800 g and 4 °C. The pellet was discarded and the new 
supernatant (SN3) was collected and pelleted 10 min at 11000 g and 4 °C. 
The new pellet containing mitochondria was washed with TH buffer without 
BSA by resuspeinding it and pelleted 5 min at 11000 g and 4 °C. The washed 
mitochondria were resuspended in TH buffer without BSA and quantified. 
They were used immediately or stored at -80 °C. 
2.2.4.2 Large scale isolation of human mitochondria 
Cells were harvested in PBS and pelleted 15 min at 4700 rpm and 4 °C. Cell 
pellets were resuspended in TH buffer with 0.1 mg BSA/ml and pottered 30x 
at 800 rpm on ice. Centrifugation steps were carried out in a JA-20 




(SN1) containing mitochondria was collected. The cellular debris was 
resuspended in TH buffer with 0.1 mg BSA/ml and pottered again 30x at 
800 rpm on ice and pelleted 20 min at 800 g and 4 °C. The pellet was 
discarded and the supernatant (SN2) was added to SN1 and pelleted 20 min 
at 1200 g and 4 °C. The pellet was discarded and the new supernatant (SN3) 
was collected and pelleted 20 min at 14000 g and 4 °C. The new pellet 
containing mitochondria was washed with TH buffer without BSA by 
resuspeinding it and pelleted 10 min at 14000 g and 4 °C. The washed 
mitochondria were resuspended in TH buffer without BSA and quantified. 
They were used immediately or stored at -80 °C. 
2.2.4.3 Isolation of human mitochondria for import 
Cells were harvested in PBS with a rubber policeman and pelleted at 600 g, 
3 min and room temperature. The pellets were transferred onto ice and 
resuspended in cold isotonic buffer with 2 mM PMSF with a plastic Pasteur 
pipette. Cells were pelleted again and resuspended in cold hypotonic buffer 
with 2 mM PMSF (5 ml / 1 g cells) with a plastic Pasteur pipette and incubated 
for 7 min. Cells were pottered 10x on ice in a glass potter by hand. Cold 
hypertonic buffer (1,1 ml/1 g)and cold isotonic buffer + 2 mg/ml BSA and 
2 mM PMSF (1,1 ml/1 g)was added to the suspension. The sample was 
pelleted10 min at 1000 g and 4 °C and the supernatant (SN1) was collected. 
The supernatant (SN1) was pelleted 10 min at 1000 g and 4 °C again and the 
new supernatant (SN2) was collected. SN2 was pelleted 10 min at 10000 g 
and 4 °C and the supernatant (SN3) was discarded. The pellets containing 
the mitochondria were washed with isolation buffer without PMSF/BSA and 
pelleted 10 min at 10000 g and 4 °C. The washed mitochondria were 
resuspended in isolation buffer without PMSF/BSA and quantified. 
Mitochondria were used for experiments after 2 h incubation on ice. 
 
2.2.5Isolation of the crude mitochondrial ribosome fraction 
2.2.5.1 Isolation via FPLC 
Mitochondriawere solubilized in solubilisation buffer (immunoprecipitation) 




pelleted 15 min at 14000 rpm and 4 °C and the supernatant was collected. 
500 µl or 5 ml supernatant were loaded onto a Superdex 200 10/300 GL or a 
HiLoad 16/600 Superdex 200 pg colum respectively with an ÄKTA purifier 
system (GE Healthcare). The fractions were collected and analyzed by 
Western blotting and the flowthrough was processed further for cryoEM 
analysis. 
2.2.5.2 Isolation via differential centrifugation 
Mitochondria were solubilized in solubilisation buffer (sucrose cushion) with 
0.5 % PCC (5 mg/ml) for 30 min at 1000 rpm and 4 °C. The sample was 
pelleted 15 min at 14000 rpm and 4 °C and the supernatant was collected. 
4 ml of the supernatant were loaded onto 3.5 ml sucrose cushion and pelleted 
15 h at 148000 g and 4 °C. The supernatant, the sucrose cushion and the 
pellet containing the crude ribosome fraction were collected and analyzed by 
Western blotting. For cryoEM analysis, only the ribosome pellet was 
processed. 
 
2.2.6Immunoisolation of proteins 
2.2.6.1Immunoisolation with endogenous antibodies 
Preparation of column 
Protein-A sepharose (PAS) beads were transferred to a Mobicoil spin column 
(MoBiTec) and the supernatant was removed by 30 s centrifugation at 100 g 
and room temperature. The beads were washed twice with 0.1 M KPi, pH 7.4 
and 200 µl antibody serum and 200 µl 0.1 M KPi, pH 7.4 were added to the 
beads. After 1 h incubation at room temperature, the supernatant was 
removed by 30 s centrifugation at 100 g. The beads were washed twice with 
0.1 M sodium tetraborate and incubated in 0.1 M sodium tetraborate with 
5 mg/ml dimethyl pimelimidate (DMP) for 30 min at room temperature. The 
supernatant was removed and the beads were washed twice with 1 M tris 
pH 7.4 and incubated in 1 M tris pH 7.4 for 12 h. The supernatant was 
removed, the beads were washed with 0.1 M glycine pH 2.8 and incubated for 




supernatant was removed and thebeads were washed three times with PBS 
and stored in PBS with 2 mM sodium azide. 
Immunoisolation 
Mitochondria were lysed in solubilizaiton buffer (immunoprecipitation) 1 µg/µl 
for 30 min at 1000 rpm and 4 °C. The sample was pelleted 15 min at 
14000 rpm and 4 °C and the supernatant was collected. The PAS column with 
cross-linked antibodies was washed three times with solubilizaiton buffer 
(immunoprecipitation) and the supernatant was transferred onto the column. 
After 1 h incubation at 4 °C, the supernatant was removed and the beads 
were washed ten times with washing buffer (immunoprecipitation). The bound 
proteins were eluted by 5 min incubation in 0.1 M glycine pH 2.8 at 750 rpm 
and room temperature and the supernatant was collected. 
2.2.6.2 Immunoisolation with Anti-FLAG M2 agarose beads 
Mitochondria were lysed in solubilizaiton buffer (immunoprecipitation) 1 µg/µl 
for 30 min at 1000 rpm and 4 °C. The sample was pelleted 15 min at 
14000 rpm and 4 °C and the supernatant was collected. Alternatively, the 
flowthrough containing the crude mitochondrial ribosome fraction (2.2.4.1) 
was used. Anti-FLAG M2 agarose beads were transferred transferred to a 
Mobicoil spin column (MoBiTec) and washed three times with solubilizaiton 
buffer (immunoprecipitation) and the supernatant was transferred onto the 
column. After 1 h incubation at 4 °C, the supernatant was removed and the 
beads were washed ten times with washing buffer (immunoprecipitation). The 
bound proteins were eluted by 30 min washing buffer (immunoprecipitation) 
with 0.4 mg/ml FLAG peptide (Sigma)at 1000 rpm and 4 °C and the 
supernatant was collected. 
2.2.6.3 Immunoisolation with Anti-FLAG M2 agarose beads from the 
crude ribosome pellet for cryoEM 
Isolated crude ribosome pellets (2.2.4.2) were lysed in solubilizaiton buffer 
(immunoprecipitation) 1 µg/µl for 30 min at 1000 rpm and 4 °C. The sample 
was pelleted 5 min at 14000 rpm and 4 °C and the supernatant was collected. 
Anti-FLAG M2 agarose beads were transferred transferred to a Mobicoil spin 
column (MoBiTec) and washed three times with solubilizaiton buffer 




After 1 h incubation at 4 °C, the supernatant was removed and the beads 
were washed ten times with washing buffer (cryoEM). The bound proteins 
were eluted by 30 min washing buffer (cryoEM) with 0.8 mg/ml FLAG peptide 
(Sigma) at 1000 rpm and 4 °C and the supernatant was collected. 
2.2.6.4 Immunoisolation with Anti-FLAG M2 agarose beads from the 
crude ribosome pellet for mass spectrometry 
Isolated crude ribosome pellets (2.2.4.2) were lysed in solubilizaiton buffer 
(immunoprecipitation) 1 µg/µl for 30 min at 1000 rpm and 4 °C. The sample 
was pelleted 5 min at 14000 rpm and 4 °C and the supernatant was collected. 
Anti-FLAG M2 agarose beads were transferred transferred to a Mobicoil spin 
column (MoBiTec) and washed three times with solubilizaiton buffer 
(immunoprecipitation) and the supernatant was transferred onto the column. 
After 1 h incubation at 4 °C, the supernatant was removed and the beads 
were washed ten times with washing buffer (immunoprecipitation). The bound 
proteins were eluted by 30 min washing buffer (immunoprecipitation) with 
0.8 mg/ml FLAG peptide (Sigma) at 1000 rpm and 4 °C and the supernatant 
was collected. The supernatant was dialyzed against washing buffer 
(immunoprecipitation) without FLAG peptide and used for mass spectrometry 
analysis. 
 
2.2.7Import of mitochondrial proteins 
Protocolls for protein import modified after (Mick et al., 2012) and protocolls 
from Alexander Panov (Panov, 2013). 
2.2.7.1 In vitro synthesis of radiolabeled precursor mitochondria 
proteins from plasmids 
In vitro synthesis of [35S]COX6A from plasmids was carried out with the TnT® 
Quick Coupled Transcription/Translation System (Promega). 3 µg pOTB7-
COX6A1 was added to 135 µl TnT® Quick Master Mix and the reaction was 
started with 15 µl10 µCi/µl[35S]methionine. After 90 min incubation at 30 °C 
and 450 rpm, 15 µl of 200 mM non-radiolabeled methionine solution were 
added to the reaction. After 1 min incubation at 30 °C, the reaction was 




2.2.7.2 In vitro synthesis of radiolabeled precursor mitochondrial 
proteins from mRNA 
In vitro synthesis of [35S] NDUFB8 from mRNA was carried out with the Flexi® 
Rabbit Reticulocyte Lysate System (Promega). The mRNA obtained by in 
vitro transcription was incubated 3 min at 65 °C and transferred on ice 
immediately. To 66 µl rabbit reticulocyte lysate, 2 µl amino acid mixture 
without methionine, 4 µl 2.5M KCl and 2 µg mRNA were added. RNAse free 
water was added to the mixture up to 90 µl. The reaction was started with 
10 µl 10 µCi/µl[35S] methionine. After 90 min incubation at 30 °C and 450 rpm, 
10 µl of 200 mM non-radiolabeled methionine solution were added to the 
reaction. After 1 min incubation at 30 °C, the reaction was transferred on ice. 
The solution was used for import experiments directly. 
2.2.7.3 Import and assembly of precursor mitochondrial proteins 
5 mM ATP were added to the import buffer before the start of the experiment. 
Mitochondrial were solubilized in import buffer with 5 mM ATP and incubated 
3 min at 30 °C and 450 rpm. The import reactions were performed at 30 °C 
and 450 rpm and started with the addition of 10 % (v/v) radiolabeled precursor 
proteins. Import reactions were stopped by the addition of the AVO solution 
after different times (45 min maximum). For the – ψ control, AVO was added 
in the beginning of the import reaction and the reaction was performed 
45 min. After the reaction, mitochondria were pelleted 10 min at 4 °C and max 
speed. The supernatant was removed and mitochondria were washed with 
SEM buffer. Samples were analyzed by BN-PAGE. 
 
2.2.8Mass spectrometry analysis of the mitochondrial ribosome 
associated MITRAC complex 
Mass spectrometry analysis was carried out by Andreas Linden from the lab 
of Prof. Henning Urlaub (Göttingen). The sample was isolated after (2.2.5.4) 
and stored at -20 °C before analysis. After the removal of detergents in the 
sample, proteins were cleaned up and digested by trypsin. The peptides were 
reduced and alkylated and separated by liquid chromatography on a Dionex 
UltiMate 3000 UHPLC+ focused (Thermo Scientific) with an analytical column 




packed in-house) and analyzed in a Orbitrap Fusion Tribrid mass 
spectrometer (thermo Scientifc). Obtained data were analyzed with MaxQuant 
(v. 1.6.0.1, Cox 2008, Nat Biotechnol) against the SwissProt/UniProt human 
database (reviewed from 14.12.16). 
 
2.2.9Electron microscopy analysis of the mitochondrial ribosome 
associated MITRAC complex 
Analysis of the sample by electron microscopy was carried out by Prof. Holger 
Stark (Göttingen). The sample was isolated after (2.2.5.3) and analyzed 
immediately. Negative steins samples were prepeared with 2 % uranyl 
formate and images were recorded with a CM200 FEG transmission electron 
microscope (Phillips). For cryoEM analysis, the sample was immobilized on 
grids with an Vitrobot™ Mark IV (Thermo Scientific) and grids were 
transferred to a Titan Krios electron microscope (Thermo Scientific) operated 
at 300 kV. A Falcon III camera (Thermo Scientific) was used to record the 
images with a magnification of 59000x, which resulted in a pixel size of 
1.16 Å. 
 
2.2.10 Polymerase chain reaction (PCR) 
PCR was performed with the KOD hot start polymerase (Novagen). 
Amplification conditions were adjusted according to the specifications of the 
manufacturer and the melting temperatures of the primers used. PCR 
produced were analyzed by agarose gels. 
 
2.2.11 DNA isolation from E. coli 
Plasmids were isolated from bacteria using the Wizard® Plus SV Minipreps 
DNA purification System (Promega) according to the specifications of the 
manufacturer and stored at -20 °C in water. 
 
2.2.12 Quick isolation of human genomic DNA (gDNA) 
The genomic DNA of MITRAC15-/- clones were isolated using the 




plate were used for the gDNA extraction. Cells were pelleted in a reaction 
tube and the supernatant was removed. 50 µl of the extract solution was 
added to the cells and cells were vortexed 15 s. Mixture was heated for 6 min 
at 65 °C and vortexed again 15 s. Mixture was heated for 2 min at 98°C and 
stored at -80 °C or used directly for PCR. 
 
2.2.13 Molecular cloning 
Molecular cloning procedures were modified after published protocols 
(Russell, 2000). Fast Digest restriction enzymes (Fermentas) were used for 
the digestion of plasmids and PCR products according to the specifications of 
the manufacturer. Ligations were preformed with the DNA Ligation Kit 
(Thermo Scientific) for 1 hour at 22 °C. Constructs were analyzed by digestion 
and agarose gel or sequencing. 
 
2.2.14 DNA electrophoresis and sequencing 
DNA fragments were visualized by agarose gel electrophoresis. Gels with 1 % 
agarose and EtBr in TAE buffer were used. Samples were mixed with 10 % 
FastDigest Green Buffer (10X) (Thermo Scientific) and run in TAE buffer at 
100 V in a Mini-Sub® Cell GT system.GeneRuler DNA Ladder mix 
(Fermentas) was used as a marker of molecular weight. DNA was visualized 
using an UVsolo TS transilluminator. 
Concentration measurement of the DNA solutions were carried out with the 
NanoVue spectrometer (GE Healthcare) at 260/280 nm. Wizard® SV Gel and 
PCR Clean-Up System kits (Promega) were used for the purification of DNA. 
DNA-sequencing was performed by Seqlab (Göttingen) and data were 
analyzed with Geneious Pro R11. 
 
2.2.15 Transformation of E. coli 
Competent E. Coli cells were generated after the protocol of Hanahan et al. 
with RbCl(Hanahan, 1983). E. Coli overnight preculture was diluted 1:100 and 
grown until OD600 = 0.3. Cells were harvested and kept on ice for 15 min and 




in 67 ml of cold RF1 buffer and suspension was incubated 30 min on ice. 
Cells were pelleted and the supernatant removed. Pellet was resuspended in 
16 ml of cold RF2 buffer and suspension was incubated 15 min on ice. 
Bacteria suspension was distributed in 100 µl aliquots, frozen in liquid 
nitrogen and stored at -80 °C. 
 
2.2.16 Gel electrophoresis 
2.2.16.1SDS-PAGE (glycin gels) 
SDS-PAGE protocols with glycin weremodified after the original protocol from 
Ulrich Karl Lämmli(Laemmli, 1970). Rotiphorese® Gel 30 (30% 
Acrylamide/0.8% bisacrylamide;37,5:1)was used as stock solution to prepare 
gels. Stacking gels used in this study contained 4 % acrylamide and resolving 
gels contained 15-17 % acrylamide. Samples were mixed with SDS-loading 
buffer before loading. Electrophoresis was performed in custom-made gel 
chambers or Mini-PROTEAN Tetra cell at 30 mA, 230 V per gel.Precision 
plusPrecision Plus Protein™ All Blue Prestained Protein Standard was (Bio-
Rad) were used as marker. 
2.2.16.2 SDS-PAGE (tris tricine gels) 
Tris tricine SDS-PAGE gels were modified after the protocol of Hermann 
Schägger(Schägger, 2006). The Hoefer gel system was used to pour gradient 
gels. 10-18 % gradients were used in this study as resolving gels and 4 % 
gels were used for stacking gels. Samples were mixed with SDS-loading 
buffer before loading. Electrophoresis was performed in custom-made gel 
chambers or Mini-PROTEAN Tetra cell at 25 mA, 80 V per gel. Precision 
plusPrecision Plus Protein™ All Blue Prestained Protein Standard was (Bio-
Rad) were used as marker. 
2.2.16.3 BN-PAGE 
Native complex separation on BN-PAGE was performed after modified 
protocols from Schägger and von Jagow(Schägger and Jagow, 1991). 
Mitochondria were solubilized in BN solubilization buffer (EDTA) and 
incubater 20 min on ice. Mixture was pelleted 15 min at 14000 rpm and 4 °C 




loading buffer (10X) and incubated 5 min on ice prior to loading. The Hoefer 
gel system was used to pour gradient gels. 4-13% or 2.5-10 % gradients were 
used in this study as resolving gels and 4 % gels were used for stacking gels. 
BN cathode and anode buffers were used for gel electrophoresis. 
Electrophoresis was performed at 15 mA, 600 V per gel at 4 °C. After 1 h 
running with 0.02% Coomassie Brilliant Blue G-250 containing BN cathode 
buffer, the cathode buffer was exchanged with Coomassie free BN cathode 
buffer. 
2.2.16.4 Western Blot 
After protein/complex separation on gel systems, proteins were transferred on 
PVDF membranes (Millipore) by semi-dry blotting(Gallagher et al., 
2001).PVDF membranes were activated by methanol and gels, PVDF 
membranes and Whatman papers (Heinemann Labortechnik) were 
equilibrated in blotting buffer prior to blotting. Proteins were transferred from 
SDS gels to the PVDF membrane at 25 V, 250 mA for 2.5h and from BN gels 
to the PVDF membrane at 25 V, 400 mA for 3h. 
2.2.16.5 Coomassie staining 
PVDF membranes (Millipore) with immobilized proteins were stained with 
Coomassie staining solution for 2 min. Stained membranes were washed with 
Coomassie destaining solution and dried before further processing. 
2.2.16.6 Immunostaining 
PVDF membranes (Millipore) with immobilized proteinswere activated with 
methanol after Coomassie staining and washed with TBST buffer.The 
activated membrane was blocked for 1 h in TBST with 5 % milk powder at 
room temperature. After the blocking the membrane was washed three times 
10 min with TBST and incubated for 1 h in primary antibody solution (in 
blocking buffer) at room temperature. The membrane was washed three times 
10 min with TBST and incubated for 1 h in HRP coupled secondary antibody 
solution (in blocking buffer) at room temperature. After three additional 
washing steps after the incubation, the antibodies bound on the 




ECL Western Blotting detection reagent (GE-Healthcare) and signals were 
visualized on medical X-ray films (Foma). 
 
2.2.17 Determination of protein concentration 
Protein concentration was determined with Bradford analysis after the 
protocol of Marion Mckinley Bradford(Bradford, 1976). Roti®-Quant reagent 
(Roth) was used for the reaction and bovine IgG (Biorad) was used as a 
standard for calibration. Samples were measured at 595 nm with the 
Eppendorf® BioPhotometer. 
 
2.2.18 Fast lysate of HEK293 cells 
Cells were harvested with PBS and pelleted 5 min at 5000 rpm and 4 °C. Cell 
pellet was resuspended in 100-200 µl fast lysate buffer and vortexed for 30 s 
at room temperature. The suspension was pelleted 3 min at 5000 rpm and 
4 °C and the supernatant was collected. Protein concentration of the 
supernatant was determined. 
 
2.2.19 Determination of complex I and IV activity 
The activities of the mitochondrial complexes I and IV were assessed by the 
Complex I Enzyme Activity Microplate Assay Kit (abcam) and the Complex IV 
Human Specific Activity Microplate Assay Kit (abcam) respectively. Cells used 















3.1 Structural analysis of the MITRAC complex associated 
with the translating mitochondrial ribosome 
 
The structure of themitochondrial ribosome has beenstudied extensively by 
cryo electron microscopy (cryoEM)recently. High resolution data exists forthe 
isolated human(Amunts et al., 2015), yeast(Desai et al., 2017) and 
porcine(Greber et al., 2015b) mitochondrial monosome.The mitochondrial 
ribosome is in direct contact with the inner mitochondrial membrane (IM) and 
the application of cryo electron tomography has even enabled in situ structural 
information of the membrane bound human mitochondrial ribosome. One 
important feature is the large mitochondrial ribosome subunit mL45, which 
was identified to mediate the contact between the mitochondrial ribosome and 
the IM(Englmeier et al., 2017). 
This study aims to gather structural information on the mitochondrial ribosome 
stalled in translation, which has not been invesigated so far, but is essential to 
understand the translation process within mitochondria. C12ORF62 was 
identified as one of the earliest MITRAC components that associates with the 
mitochondrial ribosome during the translation of COX1(Richter-Dennerlein et 
al., 2016). Therefore, C12ORF62 was used as abait, to isolate the translating 
mitochondrial ribosome, together with the early stage of the MITRAC 
complex. To this end, a HEK293-Flp-InTMT-RExTMcell line was used with a 
pcDNA5/FRT/TO-C12ORF62FLAG inserted into the Flp-In site. 
 
3.1.1 C12ORF62FLAG co-purifies with the COX1 translating mitochondrial 
ribosome 
 
To gain structural data of the mitochondrial ribosome in association with 
MITRAC, first the interaction of C12ORF62FLAGwith the mitochondrial 
ribosome was confirmed. Therefore, C12ORF62FLAG containing mitochondria 




digitonin(1 %). C12ORF62FLAGand its interaction partners were 
immunoisolated.Eluates were separated by SDS-PAGE and membranes 
wereprobed with different antibodies (Figure 17). 
 
 
Figure 17C12ORF62FLAGcopurifies with the large and the small subunit of the 
mitochondrial ribosome. Mitochondria were isolated from WT andHEK293 Tet-on cells 
expressingC12ORF62FLAGand solubilized with Mg2+ containing buffer with 1 % digitonin as 
detergent. The immunoisolation was performed via FLAG tag with anti-FLAG agarose beads. 
5 µg (0.5 %) of the solubilized mitochondria were loaded as total control and 100 % of the 
elution were loaded. The sampleswere separated using a 10 % to 18 % tricine gel. The 
Western blot was probed with antibodies against mitochondrial ribosomal proteins (uL1m: 
39S LSU; uS40: 28S SSU) and components from the MITRAC complex (MITRAC12, TIM21). 
Besides the expected MITRAC component, MITRAC12, C12ORF62FLAGalso 
copurified proteins of the small and large mitochondrial ribosomalsubunits, 
which hinted to an interaction of C12ORF62 with the mitochondrial 
monosome. A sample of WT mitochondria was used to visualize 
unspecificallypurified proteins with the anti-FLAG agarose beads. ATP5B, a 
complex V subunit, was probed to show specificity of the experiment. 
After confirming the interaction of C12ORF62FLAGwith the mitochondrial 
ribosome, the interaction of C12ORF62FLAG with nascent COX1 was assessed 
as a characteristic of actively translating ribosomes. To support this 
interaction, cytosolic translation inHEK293T cells expressing 
C12ORF62FLAGwas inhibited using emetine and [35S] methionine labelling 




Furthermore, puromycin was added to stall translation, resulting in generation 
of COX1 nascent chain fragments, as described by Richter-Dennerlein et al. 
(Richter-Dennerlein et al., 2016) (Figure 18). 
 
 
Figure 18 C12ORF62FLAGcopurifies with fragments of nascentCOX1. [35S]metabolic 
labelling was performed inHEK293T-WT and HEK293T-C12ORF62FLAGcells. Puromycin was 
used to stop the mitochondrial translation and to generate fragments of mitochondrial proteins 
in translation. Cellswere solubilized in Mg2+ containing buffer with 1 % digitonin as detergent 
and immunoisolation was performed with anti-FLAG agarose beads. 2.5 % of the solubilized 
cellswere loaded as total and 100 % of the Elution were loaded. The Fragments F1, F2, F3 
are incomplete COX1 fragments released after puromycin treatment. The HEK293T-WT 
sample serves as a control for unspecific interactions. pur: puromycin 
In this experiment, the interaction of C12ORF62FLAG with nascentchains of 
mitochondrial proteins could be confirmed. The puromycin treated sample 
displayed an overall weaker mitochondrial-synthesis due to the inhibitory 
effect of the antibiotic (Figure 18, lane 3). In the eluate, the puromycin treated 
sample contains less mature COX1, while the signals of the fragments F1, F2 
and F3 increased significantly (Figure 18, lane 6).Thosenascentproteinswere 
described by Richter-Dennerlein et al.as nascent COX1 fragments(Richter-




Based on this, we tried to characterize the mitochondrial ribosome bound 
complex in association with newly synthesized mitochondrial proteins. Hence, 
the eluates of C12ORF62FLAG after [35S] metabolic labellingwere further 
analyzedvia blue native PAGE (BN-PAGE). By using mild and non-denaturing 
elution conditions and a native gel system(2.5-10%), large molecular weight 
complexes could be detected on autoradiograms (Figure 19B). 
 
 
Figure 19C12ORF62FLAGcoisolated with a high molecular complex containing newly 
synthesized mitochondrial proteins. [35S]Metabolic labelling of newly synthesized 
mitochondrial proteins was performed similar to thatin Figure 18. Cells were solubilized in 
Mg2+ containing buffer with 1 % digitonin as detergent and immunoisolation was performed 
with anti-FLAG agarose beads and bound complexes eluted with FLAG-peptide. A) 
Denaturing 10 % to 18 % tricine gel as control to verify the effect of puromycin. 10 % elution 
and 1.875 % solubilized cells were loaded onto the gel. The fragments F1, F2, F3 are nascent 
COX1 fragments released after puromycin treatment. B) Samples were loaded onto a 2.5 % 
to 10 % blue native gel. Total: 80 µg mitochondrial were solubilized in Mg2+ containing buffer 
with 1 % digitonin. Eluate: 90 % of the eluate from the isolation was used. A higher complex 
above 880 kDa (R) containing radioactive signal can be detected. pur: puromycin 
Here,a [35S]methionine-containing signal in thehigh molecular weightarea of 




of all three samples in this experiment, the signal was of a much weaker 
intensity inthe puromycintreated sample.Since the size of a full mitochondrial 
monosome is 2.7 MDa(Amunts et al., 2015), the size of the complex R (Figure 
19B) is too small to fit.An explanation would be that the mitochondrial 
monosome disassociated during the isolation procedure or separation on the 
BN gel and the complex R in fact represents the large ribosomal subunit (1.7 
MDa(Brown et al., 2014)), associated with the nascent COX1. Puromycin 
interferes with mitochondrial translation and causes the release of nascent 
chains(Azzam and Algranati, 1973), which would lead to a lower amount 
ofribosomes interacting with nascent COX1,as displayed by thereduced 
[35S]methionine signal (lane 3, Figure 19B). Thus, in the eluates, 
C12ORF62FLAGwas able to isolate detectable amounts of the higher molecular 
weight complex without puromycin treatment (lane 5, Figure 19B) and the 
presence of the antibiotic diminishes the presence of the complex (lane 6, 
Figure 19B). This supports the conclusion that these complexes werelarge 
mitochondrial ribosomal subunits with a nascent chain.  
Considering the interaction of C12ORF62FLAG with proteins of both the large 
and small subunits of the mitochondrial ribosome (Figure 17), its co-
purification with nascent COX1 (Figure 18), and the co-isolation of a 
puromycin-sensitive higher molecular weight complex (Figure 19), 
C12ORF62FLAGrepresents an ideal tool for isolations of actively translating 
mitochondrial ribosomes. Hence, by exploiting the high efficiencies of FLAG 
immunoisolations, C12ORF62 can be used to purify the translational 
mitochondrial ribosome-associated stages of the MITRAC complex in 
significant amounts suitable for structural analysis. 
 
3.1.2 Defining solubilisation conditionsforthe ribosome-associated 
MITRAC complex 
 
In order to generate a sample for structural analysis, two important points 
have to be considered: 1. The sample must contain a sufficient amount and 
concentration of thecomplex to be analyzed. 2. The detergent used to 




detergents are needed to maintain membrane proteins in solution and to 
counteract their aggregation, they might disturb protein-protein interactions 
and disassemble complexes. For mitochondrial membrane protein complexes 
like the mitochondrial translocase(Meisinger et al., 2001) and respiratory 
chain complexes or supercomplexes(Schägger, 2002;Schägger and Pfeiffer, 
2000), digitonin is an established detergent for solubilization.Digitonin is a 
very mild detergent, which which maintains the integrity of most 
complexes,but is limited in solubilisation efficiency. 
For the isolation of mitochondrial ribosomes, Triton X-100 was used (Schmitt, 
1969;Borst and Grivell, 1971).Even thoughTritonX-100 is able to solubilize 
proteins with high efficiency, it is stringent and therefore not suitable for 
maintaining the ribosome nascent chain complex. Hence, for the purpose of 
this aim,it was favourable to use a detergent that has strong solubilizing 
properties, while maintaining the ribosome-MITRAC interaction. To identify 
the most suitable detergent,different detergents were testedduring the 
immunoisolation of C12ORF62FLAG. The interaction betweenC12ORF62 
FLAGand MITRAC proteins, as well as with mitochondrial ribosomal proteins 
wasanalyzed(Figure 20). A concentration of 1 % was chosen for the 
detergents, which are at least 20x the critical micelle concentration (CMC) of 
the various detergents and therefore provided proper solubilisation properties. 
A detergent concentration over the CMC is needed to efficiently solubilize 






Figure 20PCC provides optimal solubilisation conditions for the isolation of 
C12ORF62FLAG associated complexes. A) and B) HEK293T-WT and HEK293T-
C12ORF62FLAG mitochondria were solubilized in Mg2+ containing buffer with 1 % of different 
detergents (0.65% was tested for DDM). Isolation via agarose anti-FLAG beads were 
performed to confirm C12ORF62FLAG interactions. 1 % total and 100 % of the elution were 
loaded onto a 10 % to 18 % tricine gel. 
Some of the tested detergents, like TritonX-100, DDM (4,4′-
Diaminodiphenylmethan) or NP40 (4-Nonylphenyl-polyethylene glycol)turned 
out to be much more stringent than digitonin. In the elution of the 
immunoisolations performed with these detergents (lane 11, 12, 13, Figure 
20A), the signals of MITRAC12, COX1 and COX4I-1were decreased, showing 
reduced interaction between the bait and the MITRAC complex. The same 
was true for the interaction between C12ORF62FLAG and the mitochondrial 
ribosome, since the signal for uL1m was also reduced in those lanes. The 
effect of OBG (N-Octyl beta-D-Glucopyranoside)was even stronger and it 
disturbed the immunoisolation of the FLAG-tag itself, which means it needed 
to be tested in a lower concentration (lane 16, Figure 20A). Detergents like 
DMNG (Decyl Maltose Neopentyl Glycol), (lane 14, Figure 20A) or the 
digitonin analog GDN (Glyco-diosgenin) (lane 13, Figure 20B),on the other 




not disturb the interactions of C12ORF62FLAG. However,they 
causedC12ORF62FLAG to co-purify a recognizable amount of complex V 
subunits, like ATP5B, which is not an interaction partner of the bait and 
therefore served as a negative control. A possible explanation for this 
observation is that weaker detergents lack the ability to solubilize the 
membrane patches of mitochondria sufficiently. Therefore these detergents 
were not considered for further studies. LMNG (Lauryl Maltose Neopentyl 
Glycol) seemed to cause some loss of interaction between C12ORF62FLAG 
and the MITRAC complex subunit COX4I-1, but did not affect the interaction 
of the bait with the mitochondrial ribosomal protein uL1m (Figure 20B, Lane 
12). Of the tested detergents, only PCC (4-trans-(4-trans-Propylcyclohexyl)-
cyclohexyl α-maltoside) showed mild solubilization conditions that are 
comparable to digitonin, thereby preserving the analyzed interactions. Also, 
the negative control ATP5B was largely absent in the elution (Figure 20A, 
Lane 15). 
PCC (Figure 21) is a recently developed maltose based compound, designed 
to provide mild solubilization conditions, similar to digitonin, while having high 
solubilization efficiency. PCC was tested successfully for the crystallization of 
cytochrome b6f, as well as for Surface Plasmon Resonance studies and for 
the interaction of the solubilized receptor pair, Patched / Smoothened,of the 
Sonic Hedgehog pathway (Hovers et al., 2011). LMNG (Figure 21) also 
belongs to a group of recently developed detergents with a maltose base and 
low CMC values (Maltose Neopentyl Glycol / MNG). MNGs were designed as 
detergents that can be synthesized with low effort to serve for large-scale 
analysis of membrane proteins. LMNG in particular was shown to have 
superior membrane protein stabilizing properties in comparison to traditional 
mild detergents like DDM(Chae et al., 2010). Therefore both detergents 
seemed promising candidates for the isolation of the mitochondrial ribosome-
associated MITRAC complex. 
To compare the solubilization efficiencies of PCC and LMNG, alongside the 
commonly used DDM and digitonin, isolated HEK293T-WT mitochondria were 
solubilized in detergent-containing buffer with different detergent 
concentrations. The remaining non-solubilized fraction was pelleted and 




pellet were loaded onto gels to compare the solubilisation efficiencies of 
membrane proteins (MITRAC12, COX1), in comparison to a soluble protein 
(TACO1) (Figure 22). 
 
 
Figure 21 Structure of detergents.A) 4-trans-(4-trans-Propylcyclohexyl)-cyclohexyl α-
maltoside (PCC-α-maltoside) (modified from (Hovers et al., 2011))and B) Lauryl Maltose 
Neopentyl Glycol (LMNG)(modified from (Chae et al., 2010)). 
 
 
Figure 22PCC provides strong solublizationproperties. HEK293T-WT mitochondria were 
solubilized in buffer containing different amounts of detergent. Non-solubilized fractions were 
pelleted for 15 min at 20817 g and 4 °C. Pellets were solubilized in a volume of 1 x LD equal 
to the volume of the supernatant (95 °C 5 min). 20 µg supernatant and 20 µl solubilized pellet 




From the detergent tests it can be concluded that PCC and DDM have the 
highest solubilisation capacitiesof the tested compounds.0.05 % of PCC or 
DDM was sufficient to solubilize the membrane proteinsCOX1 and 
MITRAC12.0.1 % LMNG was requiredfor similar solubilization efficiency. In 
the case of digitonin, even 1 % was not sufficient to completely solubilize 
thetested membrane proteins.Considering that C12ORF62FLAG interactions 
were more stable in PCC in comparison to DDM, PCC was chosen as the 
detergent to use for the isolation of the mitochondrial ribosome-associated 
MITRAC complex. 
 
3.1.3 Separation of different forms of the MITRAC complex 
 
The MITRAC complex was characterized as an assembly intermediate for the 
cytochrome coxidase in human mitochondria and is also a dynamic complex 
with varying composition(Mick et al., 2012;Richter-Dennerlein et al., 
2016;Dennerlein et al., 2015).Whileearly MITRAC complex subunits, like 
C12ORF62, show copurification with proteins of the mitochondrial ribosome, 
MITRAC subunits which assemble late into the complex, like MITRAC7, do 
not interact with the mitochondrial ribosome (Richter-Dennerlein et al., 2016), 
(Mick et al., 2012)(Dennerlein et al., 2015). This leads to the assumption that 
the interaction between the mitochondrial ribosome and the MITRAC complex 
only occurs in its earlier stages and that the MITRAC complex disassociates 
from the mitochondrial ribosome during the progression of complex IV 
biogenesis. The mitochondrial ribosome-associated MITRAC complex will be 
referred to as MITRACriboand the free MITRAC complex in its later stages will 
be referred to as MITRACfree. Using blue native PAGE, the MITRAC complex 
appears ata size between 140 and 250 kDa, which most likely is MITRACfree. 
The binding of mitochondrial ribosomes to MITRAC increases its size from 
230 kDa to over 2.7 MDa(Amunts et al., 2015). This mass shift was utilized to 





3.1.3.1Separation of different forms of the MITRAC complex by size 
exclusion chromatography 
 
For the separation of MITRACribofrom MITRACfree bysize exclusion 
chromatography (SEC), thesuperdex 200 size exclusion columns were used. 
The column material provides a high resolution, in the range between 10 kDa 
and 600 kDa, and has an exclusion size of 1.3 MDa. Hence, with a size over 
2.7 MDa, MITRACribois expected to be present in the flowthrough. 
MITRACfree,with a size between 140 and 250 kDa, will be retained on the 
column and therefore separated from MITRACribo. By performing FLAG 





Figure 23Isolation strategy for mitochondrial ribosome-associated MITRAC complex 
via C12ORF62FLAG. Solubilized mitochondria are subjected to SEC,followed by FLAG 
immunoisolation. Mitochondrial ribosome containing fractions, present in the flowthrough,are 
isolated by C12ORF62FLAG. 
Figure 24shows the chromatogram and Western blot analysis of different 






Figure 24 Mitochondrialribosome-associated C12ORF62FLAG can be purified bysize 
exclusion chromatrgraphy (SEC)/immunoisolation tandem experiments. Mitochondria 
were solubilized in buffer with 1 % PCC. Mitochondrial lysatesweresubjectedto a Superdex 
200 10/300 GL column.This was followed by FLAG immunoisolationsfrom collected fractions. 
FLAG immunoisolations for C12ORF62FLAG was performed from mitochondria lysate as a 
control (Lysate). 10 µg (lysate) or 30 µl (FT, F1 – F4) totaland 100 % of the elution were 
loaded onto a 10 % to 18 % tricine gel. FT: flowthrough; F: fraction. 
As presented in Figure 24, usingSEC, large protein complexes like the 
mitochondrial ribosome could be separated successfully from smaller 
complexes like MITRACfree. It was already visible in the total of the samples 
that the ribosomal proteins from both large (uL1m) and small (mS40) 
subunitswere mainly present in the flowthrough (FT, Figure 24B, lane 3). 
MITRAC complex subunits (MITRAC12, TIM21, COX1, COX4I-1) were also 




represented in the fraction 1 (F1, Figure 24B, lane 4). COX1 and COX4I-1are 
subunits of complex IV, which has a size of around 400 kDa. Therefore, 
complex IV is able to enter the pores of the gel material and is expected to be 
present in F1. As already mentioned in 1.1.1, complex IV does not only exist 
as monomers, but also within respiratory chain supercomplexes with complex 
I and III. Supercomplexes have a sizeabove 1.3 MDa(Schäfer et al., 2006)and 
so should be present in the FT. Hence, the signals of COX1 and COX4I-1in 
the FT could belong to either MITRACribo or to respiratory chain 
supercomplexes. 
By comparing the Western blot signals of the eluate from the FT (Figure 24B, 
lane 10) with the eluate from F1 (Figure 24B, lane 11), it is apparent that 
theMITRAC complexes isolated by C12ORF62FLAG are different. Compared 
with the elution from F1, the FT eluate sample (Figure 24B, lane 10) shows a 
more intense signal for the ribosomal proteins uL1m and mS40 and weaker 
signals for MITRAC complex proteins (MITRAC12, COX1, COX4I-1, TIM21), 
as well as the bait C12ORF62FLAG (Figure 24B, lane 11). The elution from F1 
(Figure 24B, lane 10) shows strong signals for MITRACfreesubunits, while 
lacking any signals for mitochondrial ribosomal proteins. These 
resultsconfirmed the hypothesis that SEC, in combination with 
immunoisolation is a suitable approach to isolate MITRACribo independently of 
MITRACfree.  
To determine the amount of MITRACribo among the different MITRAC forms, a 
large scale C12ORF62FLAG was performed from whole mitochondrial lysate in 
parallel with the purified mitochondrial ribosome fraction. The isolated proteins 
were separated by SDS-PAGE and analyzed by colloidal coomassie staining 





Figure 25Mass spectrometric analysis of MITRACribo isolation via C12ORF62FLAGreveals 
an accumulation of mitochondrial ribosomal proteins.HEK293T-
C12ORF62FLAGmitochondria were solubilized with1 % PCC containing buffer. Mitochondrial 
ribosome fraction was purified via a superdex 200 high load 16/60 GL column and FLAG 
immunoisolation was performed in purified fraction(FT). HEK293T-WT (WT) and HEK293T-
C12ORF62FLAGwere solubilized with 1 % PCC containing buffer and FLAG 
immunopurificationswere performed directly in whole mitochondrial lysate. 100% of the 
eluates were loaded onto a 10 % to 18 % tricine gel and analyzed by colloidal coomassie 
staining and MALDI-TOF mass spectrometry. Bands are labelled with the identified proteins. 
FT: flowthrough after ÄKTA 
Interestingly, the coomassie staining of the elution of the C12ORF62FLAG 
isolation from the mitochondrial ribosome fraction (Figure 25, lane 3),showed 
a different band pattern compared to that isolated from mitochondria lysate 
(Figure 25, lane 2). According to the staining intensity, the FT sample 
contained not only much less MITRAC12 and C12ORF62FLAG, but also 
severaladditional bands, which were not visible in the C12ORF62FLAGcontrol 
sample. MALDI-TOF mass spectrometry analysis revealed that most of those 
bands represented mitochondrial ribosomal proteins. 
Therefore,MITRACribowas isolated in quantitative amounts by separation from 
MITRACfree with SEC.  
For gaining structural data, the method of our choicewascryoEM, which is an 




established with mitochondrial ribosomes. To determine if a sample is suitable 
for cryoEM analysis, a large scale isolation was performed. The generated 
sample was analyzed by negative staining and electron microscopy to assess 
sample quality. Figure 26 shows a representative picture of the EM analysis. 
 
Figure 26Purified MITRACriboshows aggregation under electron microscopy. HEK293T-
C12ORF62FLAG were solubilized with 1 % PCC containing buffer. Mitochondrial ribosome 
fraction was purified via a superdex 200 high load 16/60 GL column and FLAG 
immunoisolation was performed in the purified fraction. The sample was treated by negative 
staining and analyzed by electron microscopy. 
The analysis of the negative stained sample revealed that most of the isolated 
ribosomescould be found in larger mitochondrial ribosome containing 
complexes, which were most likely mitochondrial ribosomalaggregates. Only a 
few ribosomes existed as single particles.Single particles are required for 
cryoEM analysis of complexes. Therefore, the generated sample was not 
suitable for in-depth structural analysis. The ribosome aggregates were most 




stringent conditions for mitochondrial ribosomes. To overcome this 
experimental effect, a milder method was required for the purification of the 
mitochondrial ribosome fraction. 
 
3.1.3.2Separation of different forms of the MITRAC complex via 
differential centrifugation 
  
A well established method for the isolation of mitochondrial ribosomes is the 
use of differential centrifugation. After isolation and solubilisation, the crude 
ribosome fraction can be obtained as a pellet following a sucrose cushion 
(34 % sucrose) centrifugation. The pellet contains not only the mitochondrial 
55S monosome, but also the free 39S large and 28S small subunits, as well 
as other larger complexes like the pyruvate dehydrogenase complex 
(Spremulli, 2007). Different complexes from this sample can be separated 
further by another centrifugation step on a sucrose gradient (Pfisterer and 
Buetow, 1981). 
For cryoEM analysis a highly concentrated sample was required. Since further 
sucrose gradient fractionation would lead to a dilution of MITRACribo, it was 
decided to pellet the crude mitochondrial ribosome fraction using the sucrose 
cushion to keep the sample concentrated. However, because of the small size 
of MITRACfree(between 140 kDa and 250 kDa), these complexes will sediment 
at the surface of the sucrose cushion (Figure 27) and therefore be separated 






Figure 27 Isolation of the crude mitochondrial ribosome fraction via differential 
centrifugation. 
 
Since the crude ribosome fraction can be solubilized in a smaller amount of 
buffer to perform C12ORF62FLAG immunopurification, we aimed to increase 
the concentration of MITRACribo in the elution sample for cryoEM. Therefore, a 
small scale isolation was performed (Figure 28). C12ORF62FLAG complexes 
were isolatedfrom each of the three fractions: the remaining supernatant after 







Figure 28Successful isolation of MITRACribowith C12ORF62FLAG via sucrose cushion. 
HEK293T-C12ORF62FLAG mitochondria were solubilized with 0.5 % PCC containing buffer. 
Mitochondrial lysate was centrifuged for 15 h at 148000 g. The remaining supernatant (SN) 
and the sucrose cushion (SC) were isolated. The crude ribosome pellet was solubilized with 
0.5 % PCC containing buffer (P). Immunoisolation with anti-FLAG agarose beads was 
performed for each sample. HEK293T-WT (WT) and HEK293T-C12ORF62FLAG were 
solubilized in 500 µl 1 % PCC containing buffer and FLAG immunoisolation was performed 
directly in whole mitochondrial lysate. Totals loaded: WT: 10 µg / 1 %, C12ORF62FLAG: 10 µg / 
1 %, SN: 10 µl / 0,25 %, SC: 10 µl / 0,29 % P: 10 µl / 2 %. 100 % of the elution was loaded. 
Samples were loaded onto a 10 % to 18 % tricine gel. A) Coomassie stained membrane. B) 
Antibodyprobing of membrane. 
It was already visible aftercoomassiestaining (Figure 28A), that both the total 
and eluate of the pellet (Figure 28A lane 5, 10)had a protein composition that 
differed from the supernatant (Figure 28A lane 3, 8), the sucrose cushion 
(Figure 28A lane 4, 9) and the whole mitochondrial lysate control (Figure 28A 
lane 2, 7). This indicatedthat a separation of proteins or protein complexes by 
sucrose cushion centrifugation successfully took place.  
To verify the separation of MITRACriboand MITRACfree, Western blot analysis 
was performed and different antibodies were used to probe themembranes 
(Figure 28B). While the total of the sucrose cushion fraction(Figure 28B lane 
4) showed a stronger signal for MITRAC complex subunits like, MITRAC12 or 
TIM21, in comparison to the pellet fraction (Figure 28B lane 5), the signal for 
the ribosomal proteins,uL1m and mS40,were much weaker than in the 
pellet.This indicated a successful accumulation of the crude mitochondrial 




fraction might be assembly intermediates of the mitochondrial ribosome, or 
degradation products, which were too small in size to be pelleted into the 
crude ribosome pellet. The supernatant fraction showed no signal for 
ribosomal proteins in both the eluate and total. This indicates that the 
mitochondrial ribosomal protein subunits mostly enter the sucrose cushion 
and do not exist as free proteins. The elutionsfrom the pellet sample showeda 
higher enrichment of ribosomal proteins than the sucrose cushion sample or 
the whole mitochondria lysate control, but less MITRAC complex subunits. 
The higher ratio of mitochondrial ribosomal proteinsto MITRACfree subunits in 
the pellet samplerepresents a successful isolation of the mitochondrial 
ribosome-associated MITRAC complex. 
Having established the isolation procedure, MITRACribowas purified in large 
scalefor negative staining and electron microscopy to assess the suitability of 
the sample for cryoEM. Figure 29 shows a representative electron microscopy 









Figure 29Electron microscopy picture of purified mitochondrial ribosome-associated 
MITRAC complex shows mostly single particles. HEK293T-C12ORF62FLAG mitochondria 
were solubilized with 0.5 % PCC containing buffer. Mitochondrial lysate was centrifuged for 
15 h at 148000 g. The isolated mitochondrial ribosome pellets were solubilized with 0.5 % 
PCC containing buffer.Immunoisolation with anti-FLAG agarose beads was performed in the 
resolubilized crude mitochondrial ribosome fraction. Sample was treated by negative staining 
and analyzed via electron microscopy. 
The analyzed sample showed that the isolated complexes mostly exist as 
single particles,whichwere suitable for cryoEM structural analysis. In 
conclusion, by using differential centrifugation followed by 
C12ORF62FLAGimmunopurification, a suitable sample for structural analysis of 
MITRACribocould be generated. 
3.1.4Mass spectrometric analysis of MITRACribo 
 
To define the composition of MITRACriboin an unbiased manner, 
theMITRACribo complex was isolated from mitochondria and analyzed by 
mass spectrometry in the lab of Prof. Dr. Henning Urlaub (Göttingen) by 
Andreas Linden. Peptides were detected for 73 of the 82 known mitochondrial 
ribosomal proteins. This coverage of 90 % of mitochondrial ribosomal 




monosome.  A heat map was created for the identified subunits of the 
mitochondrial ribosome, as well as for subunits and assembly factors of 
mitochondrial complex IV. The label-free quantification  (LFQ) intensity is 
displayed for the identified proteins or protein groups (Figure 30). 
 
 
Figure 30Heat map of mass spectrometry analysis of isolated MITRACribo. MITRACribo 
was isolated from 120 mg mitochondria. The isolated complex was analyzed by mass 
spectrometry. Isolated mitochondrial ribosomal proteins and complex IV subunits and 
assembly factors are visualized in a heat map, according to their measured LFQ intensities. 
LFQ intensities correlates to the amount of isolated peptides. 
Interestingly, OXA1L, which interacts with MITRACribo (Figure 28B) was 
isolated in high amounts.Considering that OXA1L is the insertase responsible 
for the transfer of mitochondrial-synthesized proteins into the mitochondrial 
inner membrane (Wiedemann and Pfanner, 2017), an interaction of OXA1L 
with MITRACribowas expected. Furthermore, early MITRAC components, like 
MITRAC12, COX1 and COX4I-1were isolated in moderate amounts, while 
late MITRAC subunits, like MITRAC15 and MITRAC7, were only purified in 
very low amounts. In addition, the overall signal intensities of mitochondrial 
ribosomal subunits were higher than for general complex IV subunits. Hence, 






3.1.5 Structure of MITRACribo 
 
Although it has been shown to interact with the COX1 nascent chain, the 
composition and the localization of the mitochondrial ribosome-associated 
MITRAC is still enigmatic. An assessment of the composition of MITRACribo 
subunits and their interaction to each other, along with their positioning on the 
mitochondrial ribosome, will provide a structural insight into the mechanisms 
of COX1 translation and insertion into the inner membrane. To achieve 
this,we aimed to generate structural data of MITRACribousingcroyEM. 
Therefore, after the successful purification of MITRACribo, the sample was 
analysed by cryoEM in the Lab of Prof. Dr. Holger Stark (Göttingen). 
The initial step involved the selection of 1,132,000 particles. After 2D 
classification, 320,000 particles (28%) were classified as ribosomal 
complexes, while the rest were discarded (72%). The high percentage of 
unusable particles is rather unusual for the first step of refinement, 
considering that only 10 – 15 % of the picked particles are normally discarded 
after 2D classification. In this case, such a high amount of discarded particles 
is due to a highly heterogenic sample. The remaining particles underwent 3D 
classification, which led to the selection of 133,000 particles for the analysis of 
the large subunit of the mitochondrial ribosome and 83,000 for the analysis of 
the monosome (Figure 31). These particles were subjected to 3D refinement 
and post processing, which yielded 3D structures of the large subunit and the 
















Figure 32 Structure of MITRACribo. Structure model of MITRACriboyielded from cryoEM 
analysis. A), B) and C) show the structure of the free large subunit. The same orientation of 
the structure is presented in A) low resolution and B) high resolution and the typical ribosomal 
structural elements are highlighted as well as the extra density. C) shows the position of the 
extra density relative to the exit tunnel. D), E), andF) show the structure of the monosome. 
The same orientation of the structure is presented in D) low resolution and E) high resolution 
and the typical ribosomal structural elements are highlighted as well as the extra density. C) 
shows the position of the extra density relative to the exit tunnel. 
In both structures, an extra density compared to the known ribosome 
structurewas visible near the exit tunnel of the ribosome, which most likely 




isolated complexes are 4.7 Å and 7.4 Å, this mostly because of the high 
resolution of the mitochondrial ribosome itself. The resolution for the extra 
density, presumed to be MITRAC, is much lower, suggesting a high flexibility 
of this moiety. Therefore, an identification of proteins or structural elements 
within the extra density is impossible with the present dataset. Nevertheless, 
the133,000 particles selected for the structure of the large subunits were 
subjected to 3D classification again, yielding 3 different subsets for the 
structure of the large subunit, representing different states and conformations 
of the complex (Figure 33). 
 
 
Figure 33 Structure comparison of the subspecies of the isolated large mitochondrial 
ribosome subunit with MITRAC. The resolution of the putative MITRAC density and the 
presence and position of the putative t-RNA density vary in the different subspecies. 
The 3 different structures have two main differences: 1) the extra density 
located at the exit tunnel varies in its resolution, which is dependent on its 
intrinsic flexibility. 2) A structural element located in the active site of the large 
subunit in the shape of an “L”, varies in its orientation in B and C, while it is 
not present in A at all. This “L” shaped structure possibly represents a t-RNA. 
Thus, the flexibility of the putative MITRAC seems to be dependent on the 







3.2 MITRAC15 is an assembly factor that links the biogenesis 
of mitochondrial complex I and complex IV 
 
The C7ORF44/MITRAC15 protein has a sequence similarity of 16.2 % 
(determined with the Needleman–Wunsch algorithm(Needleman and Wunsch, 
1970) with the BLOSUM62 matrix (Styczynski et al., 2008) to the yeast 
assembly factor Coa1, as such, it has been annotated as a homolog of Coa1. 
In yeast, Coa1 acts downstream of the yeast Cox1 translational activator, 
Mss51, to regulate Cox1 translation and complex IV assembly. Coa1 has no 
function in Cox1 translation, but affects its assembly and therefore stability 
(Pierrel et al., 2007). Coa1 interacts with Cox14 and Coa3, which are related 
to C12ORF62 and MITRAC12 respectively. The mechanism of MITRAC15 
function has not been investigated until now (Mick et al., 2007;Mick et al., 
2010). 
MITRAC15 was first described as a MITRAC12 interaction partner by Mick et 
al. (Mick et al., 2012) and is predicted to have one intermembrane helix. 
Within this study, MITRAC15 was shown to be a protein integrated into the 
inner mitochondrial membrane, with its C-terminus facing the transmembrane 
space. Reduction of MITRAC15 protein levels by siRNA in immortalized 
fibroblasts was shown to reduce steady state levels of mature complex IV, as 
well as complex I. Also, MITRAC15 showed interactions with proteins from 
both complex IV and complex I (Mick et al., 2012). 
ACAD9 and ND2 were shown to be interaction partners of MITRAC15. 
However, the interaction of MITRAC15 with complex IV components, like 
COX1, or MITRAC subunits, like MITRAC12 or C12ORF62, is rather weak 
(Richter-Dennerlein et al., 2016; unpublished data, Richarda Richter-
Dennerlein). This result is in agreement with the study published by Guerrero 
Castillo et al. (Guerrero-Castillo et al., 2017). In this study it was shown that 
complex I biogenesis involves several different intermediates, which assemble 
individually and join together for further assembly. One of these assembly 
intermediates is the ND2 containing PP module. MITRAC15 was shown to be 
one of the first interaction partners of ND2 in the early assembly intermediate 




These data indicate that MITRAC15 possibly has a dual role in complex IV 
and complex I assembly.Whether this biochemical process represents two 
independent processes, or the biogenesis of both complexes coordinated by 
MITRAC15 at a common nexus, remains enigmatic. 
 
3.2.1 MITRAC15 is present in different complexes 
 
A potential involvement in complex I and complex IV biogenesis raises the 
question of whether MITRAC15 fulfils its role in different complexes, or if the 
biogenesis of complex I and IV have a common pre-assembly complex with 
MITRAC15 as subunit. To answer this question, a two-step immunoisolation 
was performed.MITRAC15FLAG was first isolated by FLAG-
immunoisolationunder native conditions to isolate all 
MITRAC15FLAGcontaining complexes (Figure 34, lane 4). Afterwards a 
MITRAC12 immunoisolation was performed, where endogenous MITRAC12 
antibodies were immobilized on a protein Asepharose column. The second 
immunoisolation served toisolate complexes with both MITRAC15FLAG and 
MITRAC12as subunits (Figure 34, lane 5).The elutions were analyzed by 
Western blot.  Antibodies were used for proteins of the MITRAC complex 
(MITRAC12, COX1, COX4I-1) and a protein of the PP module assembly 





Figure 34MITRAC15 associated MITRAC12 and ACAD9 do not share the same complex. 
HEK293T-MITRAC15FLAG mitochondria were solubilized in 1 % digitonin containing buffer. 
FLAG immunoisolation was performed and proteins were eluted with FLAG peptide in their 
native state. A second immunoisolation was performed in the elution sample with 
endogenous MITRAC12 antibodies.10 % of the first elution (MITRAC15FLAG IP), 100 % of the 
second elution (MITRAC12 IP) and a wildtype control (WT) were seperated on a 10 % to 18 
% tricine gel and analyzed by Western blot. 
As expected, the analysis of the FLAG-immunoisolation revealed that 
MITRAC15FLAGcopurifies both complex I and complex IV interaction partners. 
However, in the elution of the second immunoisolation with αMITRAC12, only 
MITRAC subunits (COX4I-1, COX1 and MITRAC12)were present. 
Interestingly, ACAD9 was not copurified with MITRAC12.Thus MITRAC12 and 
ACAD9 interact with MITRAC15, but not with each other in the presence of 
MITRAC15. These results indicate that MITRAC15 exists in different 
independent complexes. 
Since ACAD9 and MITRAC12 interact with MITRAC15 in different complexes, 
we wanted to further characterize those complexes. Therefore, 
immunoisolations were performed with mitochondria isolated from either 
MITRAC12FLAGor ACAD9FLAGexpressing HEK293T cells. To properly visualize 
the complexes, the elutions were first separated on a first dimension on a 4 % 
to 13 % BN-PAGE gel and then further separated, in a second dimension 






Figure 35MITRAC15 exist in different independent complexes.HEK293T-MITRAC12FLAG 
and HEK293T-ACAD9FLAG mitochondria were solubilized in 1 % digitonin containing buffer. 
Immunoisolaiton was performed with anti-FLAG agarose beads and eluted under native 
conditions with FLAG peptide. 2.8 %total and 100 % elution weresubjected onto a 4 % – 13 % 
blue native gel with a 10 % to 18 % tricine gel in the second dimension. 
Analyzing the totals of both samples, it can be observed that MITRAC15 
seems to be present in complexes above 250 kDa. However, MITRAC15 is 
only barely present in the MITRAC complex, which runs between 250 kDa 
and 150 kDa. This is in accordance with the data provided by Ricarda Richter-
Dennerlein (Richter-Dennerlein et al., 2016; unpublished data, Richarda 
Richter-Dennerlein), which shows an interaction of MITRAC15 with MITRAC 
components, as well as with ND2 and ACAD9. Additionally, there is a smaller 
complex of unknown composition, around 70 kDa, visible for MITRAC15. 
In the elution of the MITRAC12FLAGimmunoisolation, MITRAC15 was present 
in a complex below 250 kDa and interestingly, also in another complexaround 
440 kDa. While the smaller complex fits the size of the MITRAC complex, the 
larger complex,around 440 kDa would fit the size of the PP module assembly 
intermediate(Guerrero-Castillo et al., 2017).Considering that ACAD9 did not 
comigrate with MITRAC12 in this complex, and MITRAC12 was not reported 
to be part of an assembly intermediate of the PP module, the complex around 
440 kDa cannot be defined with the available data. Furthermore MITRAC12 
didinteract with ACAD9 in a complex above 440 kDa, which is an area where 
MITRAC12 did not display any MITRAC15 interaction. The interaction 
between MITRAC12 and ACAD9 was also observed in the isolation of 




data, Richarda Richter-Dennerlein).Therefore, MITRAC12 interacts with both 
ACAD9 and MITRAC15 in complexes independent from each other. 
In the elution of the ACAD9FLAGimmunoisolation, MITRAC15 only appeared in 
the complex around 440 kDa. ACAD9 also coisolated ND2, which comigrated 
in the same complex as MITRAC15. Hence, this complex where MITRAC15 
and ND2 comigrate should represent an assembly intermediate of the PP-b 
module. This experiment clearly showed that MITRAC15 is associated with at 
least three different complexes; the putative PP module assembly intermediate 
(around440 kDa), the MITRAC complex (below 250 kDa) and another 
undefined complex at 70 kDa. 
 
3.2.2 MITRAC15 copurifies with newly synthesized mitochondrial 
proteins 
 
MITRAC15 is present in both an assembly intermediate for complex IV and in 
an assembly intermediate for complex I. Since mitochondrial OXPHOS 
assembly intermediates contain newly synthesized mitochondrial-encoded 
protein, it can be speculated that MITRAC15 co-isolates mitochondrial-
encoded core subunits of complex IV or complex I. To investigate this, 
HEK293T-MITRAC15FLAG cells were pulse labelled with [35S] methionine. The 
assembly of complex I was described as a slow process, up to 24 h 
(Guerrero-Castillo et al., 2017) and so labelled cells were chased for 12 h in 
[35S] methionine free media to analyze later assembly intermediates with a 
different protein composition. A FLAG immunoisolation was performed to 






Figure 36MITRAC15 copurifies with newly synthesized mitochondrial proteins. 
HEK293T-MITRAC15FLAG cells were labelled for 1 h with [35S] methionine andeither harvested 
or further chased for12 h in [35S] methionine free media. Cells were solubilized in 1 % 
digitonin containing buffer. Immunoisolaiton was performed withFLAG agarose beads. 1.1 % 
total and 100 % elution were subjected on a 10 % to 18 % tricine gel. 
This experiment showed that MITRAC15FLAG is able to coisolate different 
newly synthesized mitochondrial proteins from complexes I and IV. However, 
ND2 was particularly enriched in the MITRAC15FLAG eluate. This result is in 
agreement with published data (Guerrero-Castillo et al., 2017), showing that 
MITRAC15 is one of the first assembly factors that interacts with ND2. ND3 
and ND4L, which are later subunits of the PP-b module (Guerrero-Castillo et 
al., 2017), could also be coisolated with MITRAC15FLAG, but to a lesser extent. 
As expected from previous results of Ricarda Richter-Dennerlein (Richter-
Dennerlein et al., 2016; unpublished data, Ricarda Richter-Dennerlein), 
MITRAC15 shows only a weak interaction with complex IV subunits such as 
COX1 and COX2/COX3. 
3.2.3 MITRAC15 coisolates with fragments of newly synthesized 
mitochondrial proteins 
 
MITRAC15 is one of the first interaction partners of newly synthesized ND2 




ribosome. It was of interest to determine whether MITRAC15 could copurify 
nascent chains of mitochondrial-synthesized proteins. To investigate this, 
[35S] methionine labelling of newly synthesized mitochondrial proteins was 
performed in HEK293T expressing MITRAC15FLAG. After interruption of 
mitochondrial translation by puromycin treatement, MITRAC15FLAG was 
immunoisolated and the elution was seperated on a 10 % to 18 % tricine gel. 
Proteins were transferred by Western blot and analyzed by autoradiography. 
Since ACAD9 is a main interaction partner of MITRAC15 and also one of the 
first subunits in the PP-module assembly intermediate, the same experiment 
was performed with ACAD9FLAG expressing cells (Figure 37). 
 
 
Figure 37 MITRAC15 and not ACAD9coisolates nascent chains of newly synthesized 
mitochondrial proteins.[35S] methionine labelling of newly synthesized mitochondrial 
proteins was performed inACAD9FLAGor MITRAC15FLAG expressing HEK293T cells with and 
without puromycin treatment. 1.9 % total and 100 % elution were seperated on a 10 % to 
18 % tricine gel. 
Similar to the experiment performed with C12ORF62FLAG (Figure 18), 
puromycin treatment led to a general decrease in translation. This inference 




the puromycin treated sample (Figure 37, lane 3, 5). A corresponding 
difference was also observed in the elution, where the puromycin treated 
samples (Figure 37, lane 8, 10) showeda lower amount of coisolated newly 
synthesized mitochondrial proteins. Interestingly,in the isolation 
ofMITRAC15FLAGafter puromycin treatment(Figure 37, lane 10),three 
puromycin dependent bandsappeared (Figure 37F1, F2, F3). Thesee 
uncharacterized fragments may represent nascent chains of mitochondrial 
proteins stalled in synthesis. Considering that MITRAC15 is one of the first 
interaction partners of ND2, it is possible that those fragments are ND2 
nascent chains.  
Unlike MITRAC15, ACAD9 was not able to copurify these fragments (Figure 
37F1, F2, F3). Puromycin treatment only led to a generallower amount of 
newly synthesized mitochondrial proteins that coisolate with ACAD9 (ND2, 
ND1, COX2/3, ND4L). If the nascent chain fragments belong to ND2, the 
interaction of MTIRAC15 with ND2 would precede the interaction of ACAD9 
with ND2 and make MITRAC15 a candidate for a translation regulator of ND2. 
 
3.2.4 Knockdown of TIM21 causes accumulation of MITRAC15 at the 
MITRAC complex 
 
TIM21 was characterized by Mick at al. 2012 as a shuttle protein that 
transports complex IV subunits of cellular translational origin from the import 
machinery to the assembly intermediates. TIM21 could be stalled at the 
MITRAC complex, or the translocase, after inhibition of cellular or 
mitochondrial translation respectively. Additionally, TIM21 interacts with newly 
synthesized mitochondrial proteins of all OXPHOS complexes, suggesting 
that the TIM21 function extends beyond just complex IV assembly(Mick et al., 
2012).  
The interaction between MITRAC15 and TIM21 was similar regardless of 
whether TIM21 was shifted to the respiratory complexes or to the translocase 
(Mick et al., 2012). This raised the question if TIM21 can influence the shifting 
of MITRAC15 between its complexes. Therefore, to investigate the role of 




knockdown of TIM21 in HEK293T cells expressing MITRAC15FLAG was 
performed with following isolation of MITRAC15FLAG. The eluates were 
analyzed by Western blotting (Figure 38A). The experiment was also 
performed with [35S] methionine labelling,prior to FLAG immunoisolation, to 
adress the effect of a TIM21 knockdown on the interaction of MITRAC15FLAG 
with newly synthesized mitochondrial proteins (Figure 38B). 
 
 
Figure 38Knockdown of TIM21 causes a higher association of MITRAC15 with the 
MITRAC complex. HEK293T cells expressing MITRAC15FLAGwere labelled 1 h with [35S] 
methionine. Cells were solubilized in buffer containing 1 % digitonin. Immunoisolation was 
performed with FLAG agarose beads. Totals and eluates were separated on a 10 % to 18 % 
tricine gels. A) Western blot analysis was performed usingthe above mentioned antibodies. 
10 µg total wereused. B) Analysis of newly synthesized mitochondrial proteins after [35S] 
methionine labelling. 15 µg total were used. 
Interestingly, upon loss of TIM21, MITRAC15 displayedincreased association 
to the MITRAC complex. This could be observed in the eluates of the 
MITRAC15FLAG isolation in HEK293T cells (Figure 38A, lane 5, 6) and after 
[35S]methionine labelling of newly synthesized proteins (Figure 38B, lane 3, 
4). In the analysis of the non-radiolabeled sample, MITRAC15 isolated more 




sample, while its interaction with the PP-module assembly intermediate 
subunits ND2 and ACAD9 was not changed (Figure 38A). Additionally, in the 
case of newly synthesized proteins, MITRAC15 specifically isolated more 
COX1 after TIM21 depletion, while the other interactions were not affected 
(Figure 38B). The observed accumulation of MITRAC15 seems to be specific 
for the MITRAC complex. Hence, TIM21 may function as a shuttle to 
disslocate MITRAC15 from the MITRAC complex. 
3.2.5 ACAD9 is needed for further assembly of the PP-module 
 
ACAD9 is one of the first interaction partners of MITRAC15 in the PP-b 
module assembly and was shown to be required for complex I assembly 
(Nouws et al., 2010;Guerrero-Castillo et al., 2017).Hence, it can be proposed 
that a defect in the assembly of complex I would shift the interaction of 
MITRAC15 to the MITRAC complex. Toanalyze the interactions of MITRAC15 
in cells with impaired complex I assembly, an siRNA mediated knockdown 
ofACAD9 in HEK293T cells expressing MITRAC15FLAG was performed and 







Figure 39ACAD9 depletion impairs assembly of the PP-module, but does not affect ND2 
binding of MITRAC15. MITRAC15FLAGexpressing HEK293Tcells were solubilized in buffer 
containing 1 % digitonin. Immunoprecipitation was performed with FLAG agarose beads. A) 
Western blot analysis of complex I proteins (ND2, ACAD9) and complex IV proteins (COX1, 
COX4I-1, COX6A) by antibody probing. 1.4 % total and 100 % of elution. B) Analysis of newly 
synthesized mitochondrial proteins after 35S methionine labelling. 1.7 % total and 100 % of 
elution.C) Relative amount of newly synthesized ND2 standardized to ND2 levels in NT 
cells.SEM, N = 3. Protein level in NT set to 100 %.D) Amount of PP-module subunits in the 




Unlike the knockdown of TIM21, the depletion of ACAD9 in cells did not cause 
the accumulation of MITRAC15 in the MITRAC complex. Even though 
MITRAC15 loses it’s interaction with ND2, suggesting a lower association of 
MITRAC15 with the PP module assembly intermediate, it’s interaction with 
complex IV proteins was not affected (Figure 39A).Hence, the function of 
MITRAC15 in complex I and IV seems to be independent from each other. 
Also,knockdown of ACAD9 did not lead to a reduction of total ND2 protein 
levelsin the cell (Figure 39A, lane 2, 3), but only reduced the interaction of 
MITRAC15 with ND2 (Figure 39A, lane 5, 6). Therefore,ACAD9 might be 
needed for the interaction of MITRAC15 with ND2.However,this assumption is 
contradicted by the interaction of MITRAC15 with newly synthesized 
mitochondrial proteins(Figure 39B – D). Even though the effectiveamount of 
newly synthesized ND2 that coisolated with MITRAC15FLAGwas lower in the 
siACAD9 treated sample compared to the NT sample (Figure 39B, lane 3, 4), 
the relative amount of newly synthesized ND2 was similar in both samples 
(Figure 39D). The lower effective association of MITRAC15 with newly 
synthesized ND2 in the siACAD9 treated sample compared to the NT sample 
is caused by a reduction in the synthesis of ND2 by 40 % (Figure 39C).  
In consideration, a more fitting explanation for the reduction of ND2 
association with MITRAC15 is that the reduction of ACAD9 protein levels in 
cells impairs the further assembly of the PP-b module. The impaired assembly 
causes the ND2 and MITRAC15 containing complex to disassemble. 
However, siRNA mediated depletion of ACAD9 also caused a reduction in the 
interaction of newly synthesized ND3 and ND4L with MITRAC15FLAG (Figure 
39B, lane 3, 4). This observation could also be confirmed in the quantification 
of the relative amount of coisolated ND3 and ND4L, which wasnormalized to 
the protein levels in the totals (Figure 39D). This might be explained by the 
fact that ND3 and ND4L join the PP-b module at a later stage (Guerrero-
Castillo et al., 2017), which implies that ACAD9 is required for PP-b module 
maturation at a later stage than MITRAC15. Therefore, the obstruction of the 
PP-b module assembly, caused by depletion of ACAD9,may also leads to the 
disassembly of the MITRAC15 and ND2 containing complexpreventing the 




3.2.6Generation and analysis of a MITRAC15-/-cell line 
 
To characterize the function of MITRAC15 in more detail, a knockout cell line 
(MITRAC15-/-) was generated using CRISPR/CAS9-mediated genome editing. 
The MITRAC15 gene consists of 5 exons, where the first exon only encodes 
the first 5 amino acids. Therefore, for the generation of a MITRAC15-/- cell 
line, both the second and the third exons were targeted. After single cell 
sorting and cell expansion, colonies were analyzed byWestern blotting. 
Clones where the signal for MITRAC15 was absent were further analyzed. To 
verify the knockout, PCR products of the MITRCA15 gene were sequenced. 
One clone had a homozygous stop codon insertion in exon 2. This mutant 
was chosen for further characterization (Figure 40). The other clones carried 
point mutations or frame shift mutations within the MITRAC15 gene. 
 
 
Figure 40 Nucleotide alignment of sequenced MITRAC15-/- clone and WT exon 2 
sequence. Position of the stop codon is highlighted. 
 
3.2.6.1 MITRAC15 affects ND2 synthesis but not complex I and complex 
IV activity 
 
Since MITRAC15 is involved in the biogenesis of complex I and complex VI, It 
was assumed that a knockout of MITRAC15 would affect the stability or 
synthesis of mitochondrial-encoded subunits in complex I and IV. In particular, 
ND2 might be influenced by the knockout of MITRAC15, since MITRAC15 
showed strong interaction with newly synthesized ND2 (Figure 36) and 




MITRAC15 knockout was investigated on complex IV and complex I subunits 
by different biochemical approaches (Figure 41).  
 
 
Figure 41 ND2 steady state levels and synthesis is decreased in MITRAC15-/- cells. A) 
WT and MITRAC15-/-HEK293Tmitochondria were solubilizedin buffer containing 1 % 
digitonin. B) [35S] methionine labelling of newly synthesized mitochondrial proteins were 
performed in WT and MITRAC15-/-HEK293Tcells with 1 h pulse and harvested directly or after 
12 h chase in [35S] methionine free medium. C) Quantification of ND2 signal intensityof pulse 
labelled samples in B) relative to the WT sample. Values normalized to ATP8 protein levels. n 
= 1 D) Quantification of ND2 signal intensity of samples in B) relative to the pulse samples. 
Values normalized on ATP8 protein levels. n = 1 
Firstly, steady state protein levels from isolated mitochondria were analyzed 
(Figure 41A).A specific reduction in ND2 was observed as a result of knockout 
of MITRAC15. COX1, the core complex IV subunit and ACAD9, another 
assembly factor of the P module, were not affected.Furthermore, newly 
mitochondrial-synthesized proteins were labelled with [35S] methionine to 
investigate changes in mitochondrial protein synthesis (Figure 41B, lane 1, 2). 




labelling (Figure 41B, lane 1, 2), the relative ND2 signal intensity,ofthe pulse 
labelled samples was quantified for a more precise comparison (Figure 41C). 
The signal intensities were normalized to the intensity of the ATP8 signal. 
Furthermore, the normalized ND2 signal intensity of the WT sample was set 
to 100 %, while the normalized ND2signal intensity in the MITRAC15-/- sample 
was calculated relative to the WT sample. Quantification revealed a reduction 
of ND2 synthesis by 44 % in MITRAC15-/- cells (Figure 41C). To assess the 
stability of the radiolabeled mitochondrial-synthesized proteins, a second set 
of [35S] methionine labelled cells were chased for 12 h with radioactive-free 
medium before harvesting (Figure 41 B, lane 3, 4). To assess the stability of 
ND2, the signals in all 4 samples (Figure 41B) were quantified and normalized 
to ATP8. The normalized ND2 signal in the pulse labelled samples were set to 
100 % and the normalized ND2 signal in the chased samples were calculated 
relative to the corresponding pulse labelled sample (Figure 41D). The 
quantification of the 12 h chase showed that the relative decrease of the 
radiolabeled ND2 signals were similar in WT (82 % reduction) and 
MITRAC15-/- (86.5 % reduction) cells, showing that a knockdown of 
MITRAC15 does not affect the turnover rate of ND2.Therefore, MITRAC15 
has a role in ND2 synthesis, but no influence onit’s stability. 
ND2 is one of the structural core subunits of mitochondrial complex I and 
actively takes part in proton transfer. Hence, the reduction of ND2 protein 
levels in MITRAC15-/- cells might also influence the net activity and stability of 
complex I. Complex I oligomerises with complex III and IV into 
supercomplexes to enhance the electron transfer between the OXHPOS 
complexes (Bianchi et al., 2004). Therefore, a defect in complex I might also 
affect the performance of complex III and IV. To investigate the validity of this 
assumption, an ELISA assay was performed to quantify complex I and IV 
activity in mitochondria (single complexes and different supercomplexes)  
(Figure 42).Mitochondria were solubilized with the buffer provided along with 
the kit and complexes, I or IV, were immobilized in wells of a 96 well plate with 







Figure 42 MITRAC15-/- cells display similar complex IV and complex I activities to WT 
cells. ELISA assay kits were used with WT and MITRAC15-/-HEK293Tcells. SEM,n = 3 . 
Despite the severe reduction of ND2 in MITRAC15-/- cells on steady state, the 
activities of complex IV and complex I were not significantly affected. This 
finding contradicts the reduced production of nascent ND2 as observed in 
Figure 41. This can either be explained by the fact that the remaining ND2 
serves to form assembled complex I similar to WT cells, or complex I retains 
its stability and catalytic activity even without ND2 being present. 
3.2.6.2 MITRAC15-/- causes increase an in complex IV assembly 
 
Despite reducing ND2 synthesis by 45 % (Figure 41), a knockout of 
MITRAC15 did not cause a significant reduction in the activity of the OXPHOS 
complexes I and IV (Figure 42). To further investigate the consequences of 
the MITRAC15 knockout, a more sensitive method was chosen to monitor the 
assembly of complex I and IV. Protein imports of[35S] methionine-labelled 
subunits of complex I and complex IV into mitochondria were performed and 
their assembly into the mature complexes was monitoredby BN-PAGE. Since 
assembly defects are most obvious by the investigation of late complex 
constituents, the NDUFB8 and COX6A subunits were chosen for complex I 
and IV respectively (Figure 43). Both NDUFB8 and COX6A assemble at late 
stages into their corresponding complexes (Lazarou et al., 2009), (Guerrero-






Figure 43 MITRAC15-/-has no effect in the assembly of complex I but leads to increase 
in complex IV assembly.Radiolabeled NDUFB8 and COX6A were imported into HEK293T-
WT and HEK293T-MITRAC15-/- mitochondria. A) Mitochondria were solubilized in buffer 
containing 1 % digitonin after import, 90 µg solubilized mitochondria were subjected to BN-
PAGE (NDUFB8: 2.5 – 10 %; COX6A: 4 – 13 %) to observe assembly of the subunits. B) 
Quantification of the assembly of NDUFB8 and COX6A into their complexes in A). Values are 
relative intensities normalized on the intensity of the WT sample at the last time point. 
The import and assembly of NDUFB8 occurred into a complex of around 440 
kDa, corresponding to the predicted size of the PD-b module (Guerrero-
Castillo et al., 2017). The further assembly of this intermediate into the mature 
complex I, or later intermediate assembly stages,could not be seen in this 
experiment. However, knockout of MITRAC15 did not affect the assembly of 
NDUFB8 into the PD-b module. 
Interestingly, a clear increase of assembled COX6A into complex IVcould be 
observed. However, the import efficiency of COX6A was similar between 




is involved in quality control during complex IV assembly steps.Furthermore, it 
has to be mentioned that even though the import of COX6A was largely 
membrane potential dependent, a fraction of the protein was still imported and 
assembled into the mature complex IV while membrane potential was absent 
(Figure 43 COX6A, lane 6, 12).Similar import behaviour has been reported for 































4.1 Assessing the composition of the mitochondrial 
ribosome-associated MITRAC 
 
The regulation of mitochondrial translation has been characterized in detail 
forthe yeast Saccharomyces cerevisiae. A number of translation factors are 
known to act on either the mitochondrial mRNA, or to interact with the 
mitochondrial ribosome to promote the translation(Dennerlein et al., 2017). In 
humans, the regulation of mitochondrial translation is mostly enigmatic. Aside 
from TACO1, which is known to interact with the COX1 mRNA(Richman et al., 
2016), only C12ORF62 and MITRAC12 was shown to specifically affect the 
translation of an individual mitochondrial protein, COX1(Mick et al., 2012). 
Originally characterized for its role in COX1 translation (Weraarpachai et al., 
2012),(Mick et al., 2012), Richter-Dennerlein et al. were able to show that 
C12ORF62 is present during the translation of COX1 and can copurify its 
nascent chains when the mitochondrial translation is stalled(Richter-
Dennerlein et al., 2016). In this study, early stage MITRAC, which is 
associated with the mitochondrial ribosome (MITRACribo), was isolated. This 
was used to generate a structural model using cryoEM. 
 
4.1.1 Early assembly of complex IV 
 
In the Western blot analyses of the purified MITRACribo, we were able to see 
not only mitochondrial ribosome subunits, but also the structural subunit 
COX4I-1 and the shuttle protein TIM21 (Figure 24, Figure 28). This indicates 
that the assembly of the cytochrome c oxidase already begins during or 
shortly after COX1 translation, at which point the ribosome-association of 
MITRAC still prevails. Our findings contradict with the early assembly models 
proposed recently. Bourens et al. (Bourens and Barrientos, 
2017a)characterized CMC1 as an assembly factor of complex IV, which is 




ribosome(MITRACfree). CMC1 was shown to interact with MITRAC12, 
C12ORF62 and COX1 and it also comigrates with them in the MITRACfree 
complex. An interaction of CMC1 and COX4I-1 was not detected. Therefore, 
Bourens et al. proposed that CMC1 joins MITRACfree and disassembles from 
the complex prior to the assembly of COX4I-1. MITRACribo, which is 
associated with the COX1 translating mitochondrial ribosome, predates the 
formation of MITRACfree. The observation that COX4I-1 already associates 
with MITRACribo(Figure 24, Figure 28) contradicts the claim by Bourens at al. 
that COX4I-1 assembles onto MITRACfree after the disassembly of 
CMC1.Vidoni et al. (Vidoni et al., 2017) proposed a similar assembly model of 
complex IV in a study about the newly identified assembly factor MR-1S. In a 
mass spectrometry of mitochondria solubilized with DDM and loaded onto a 
blue native gel, Vidoni et al. identified a small complex containing HIGD1A, 
COX4I-1 and COX5A. They propose that this complex represents a modular 
assembly intermediate, which assembles onto MITRACfree. Because of the 
use of DDM as a detergent, these results are arguable. Unlike digitonin, DDM 
is a rather harsh detergent, which disturbs the interaction of COX4I-1 with 
MITRAC (Figure 20). Therefore, it is questionable whether the HIGD1A, 
COX4I-1 and COX5A complex forms on its own in vivo, or disassembles from 
a complex IV assembly step. Nevertheless, it is necessary to verify the 
presence of COX5A with MITRACribo to further clarify this observation. Taking 
the results ofVidoni et al. (Vidoni et al., 2017) and Bourens et al. (Bourens and 
Barrientos, 2017a) into account, it is possible that variations exist in the early 
assembly of complex IV, allowing cytosolic translated subunits to be added to 
MITRAC at different steps. Figure 44shows a putative early assembly model 





Figure 44 Putative early assembly of mitochondrial complex IV. Assembly of nuclear 
encoded subunits (COX4I-1, COX5A?) into MITRAC can occur during COX1 synthesis or 
after MITRAC disassociates from the mitochondrial ribosome. CMC1 participate in complex 
IV assembly if COX4I-1 is not assembled into MITRAC during COX1 translation. 
 
4.1.2 Structure of MITRACribo 
 
In recent years, several milestones were set in the study of mitochondrial 
ribosomes by the use of electron microscopy. CryoEM analyses yielded high 
resolution structural data for mitochondrial ribosomes in human (Amunts et 
al., 2015), yeast (Desai et al., 2017) and porcine (Greber et al., 2015b) and 
provided an insight into the mechanism of this complex machinery. 
Nevertheless, the process of translation initiation in human mitochondrial 
ribosomes has remained enigmatic. The MITRAC subunit,C12ORF62,is one 
of the few known human translation factors and was shown recently to 
associate with the COX1 translating ribosome (Richter-Dennerlein et al., 
2016). By using cryoEM, we hoped to gain more insight into the interaction 
between MITRAC and the mitochondrial ribosome. 
The traditional detergents used to isolate the mitochondrial ribosome and the 
cytochromec oxidase are Triton X-100 and digitonin respectively. While Triton 
X-100 provides high solubilisation capacities for mitochondrial proteins 
(Spremulli, 2007), digitonin provides mild solubilisation conditions for complex 




suitable for our purpose, because Triton X-100 disturbs the interaction 
between MITRAC and the mitochondrial ribosome (Figure 20) and the 
solubilisation capacity of digitonin is insufficient (Figure 21). After assessing 
the stringency (Figure 20) and solubilisation capacity (Figure 21) of several 
detergents, PCC turned out to be the optimal detergent for this purpose. It 
belongs to a group of recently developed detergents for crystallography 
(Hovers et al., 2011) and provided both mild solubilisation conditions, to keep 
the complex intact and high solubilisation capacity to provide a concentrated 
sample for cryoEM analysis. 
Even though a sample for cryoEM analysis could be generated, the sample 
quality was rather poor. A high amount (72 %) of the 1,132,000 picked 
particles had to be discarded as unusable. Furthermore, a large part of the 
isolated complexes are not the mitochondrial monosome, but consist of only 
the large subunit. Since the mitochondrial ribosomes isolated with MITRAC 
should be stalled in the process of COX1 translation, they should be present 
as monosomes and not single large subunits. The high amount of free large 
subunits and not usable particles indicates a decay of the isolated complexes 
during or after the isolation. Hence, optimizing buffer and isolation conditions 
might raise the yield of suitable complexes. 
Nevertheless, the average resolution of the isolated large subunits could be 
refined to 4.7 Å, which is still a lowerresolution than the 3.4 Å of the existing 
structure of the large mitochondrial ribosomal subunit (Brown et al., 2014), but 
sufficient to see structural details of proteins and the 16S rRNA. Still, this 
resolution is only present in the structure of the ribosomal subunit itself. The 
putative MITRAC complex can only be visualized at a lower resolution that 
does not provides information of its composition. The cause of the low 
resolution is most likely the high mobility of the complex, which is known for 
causing lower resolutions for cryoEM analysis in general (Subramaniam et al., 
2016). The mobility of the putative MITRAC complex on the ribosome could 
be caused by the intrinsic flexibility of the ribosome-associated MITRAC, 
which can be influenced by the conformation changes during COX1 
translation. An argument for the influence of the mitochondrial translation 
process on MITRAC flexibility is the subset of structures generated by a 




ribosomal subunit (Figure 33). Among these three structures, the putative 
MITRAC complex shows the highest flexibility while the putative t-RNA 
density is not present in the active site. In contrast it’s flexibility is the lowest 
when the putative ”L” shaped tRNA density is oriented parallel to the central 
protuberance-exit tunnel axis. If the status of the putative t-RNA density 
represents different steps during translation, this suggests that changes in the 
flexibility of MITRAC dependent on the translation procedure.  
The low-density structure of the putative MITRAC can provide an insight into 
the localization of the complex relative to the mitochondrial ribosome. Both the 
structure of the free large subunit and the monosome show that the putative 
MITRAC density interacts with the large subunit of the mitochondrial 
ribosome, while it is localized at the exit tunnel. Considering C12ORF62 can 
isolate nascent COX1 chains released from the mitochondrial ribosome by 
puromycin(Richter-Dennerlein et al., 2016), C12ORF62 should interact with 
the nascent COX1 chains directly. This is facilitated by the localization of 
MITRAC at the exit tunnel of the mitochondrial ribosome. Furthermore, the 
insertase OXA1L (Bonnefoy et al., 1994) could be coisolated with MITRACribo, 
which suggests a role of OXA1L in the insertion of the nascent COX1 into the 
inner mitochondrial membrane, as has been shown in yeast (Bonnefoy et al., 
2009). Even though OXA1L was shown to substitute its homologue Oxa1 in 
yeast (Bonnefoy et al., 1994), a shRNA knockdown of OXA1L only caused a 
decrease in steady state levels of complex I and V, whereascomplex III and IV 
were not affected by a knockdown of OXA1L (Stiburek et al., 2007). These 
data imply the possibility, that other uncharacterized proteins in human 
mitochondria can substitute the function of OXA1L.  
To more thoroughly assess the composition and interaction of the MITRAC 
subunits relative to each other and also with the mitochondrial ribosome, more 
structural data is required. A way to improve structural data in general is to 
reduce the flexibility of the target. Chloramphenicol is an antibiotic that stalls 
translation in bacteria bybinding to the A site of the active center of the 
bacterial ribosome, thereby enhancing the stability of the monosome (Pathak 
et al., 2016;User, 2001).Specifically, chloramphenicol binds to the 23S rRNA 
of the 50S large subunit in bacteria and interacts with 7 bases localized 




largelyconserved between the human mitochondrial ribosome and its bacterial 
ancestors except for the missing A finger (position 827–942) and uL25m 
(Brown et al., 2014), both of which do not participate in the interaction with 
chloramphenicol. Hence, chloramphenicol might also be used to stall 
mitochondrial translation at a specific step. Nevertheless, the intrinsic 
flexibility of the ribosome-associated MITRAC still remains. A more promising 
way to improve the resolution of the present structural model is to perform 
crosslinking within MITRACribo. Crosslinking data can provide an insight into 
the interaction sites of MITRAC subunits, both with each other and with the 
mitochondrial ribosome, which together with the obtained structure, would 
improve the understanding of the structure and composition of MITRACribo. 
 
4.2 MITRAC15, acoordinator of complex I and IV assembly 
 
Initially characterized in a study by Mick et al. in 2012 (Mick et al., 2012), 
MITRAC15 was shown to associate with subunits of complex I and IV and 
was implicated in the assembly of both complexes. More recently, Guerrero 
Castillo et al. (Guerrero-Castillo et al., 2017) undertook a systematic approach 
to define assembly modules for complex I and showed that MITRAC15 
comigrates in the earliest assessable assembly intermediate of the PP-b 
module. In this thesis, further insights into MITRAC15 function could be 
provided. The key findings that come from the work presented in this thesis 
are: 1) MITRAC15 is present in distinct assembly intermediates of complex I 
and IV 2) A knockdown of TIM21 increases the association of MITRAC15 with 
the MITRAC complex. 3) A MITRAC15-/- cell line displays enhanced assembly 
of complex IV and decreased synthesis of ND2. 4) ACAD9 could be shown to 
be crucial in promoting the assembly of later subunits of complex I, like ND3 
or ND4L, into the PP-b module. 5) MITRAC15 shows strong association with 
newly synthesized ND2 and can coisolate nascent chains of mitochondrial-
synthesized proteins after puromycin treatment. 
By performing 2D PAGE analysis of isolated mitochondria, several complexes 
containing MITRAC15 were detected(Figure 35). It was observed that 




around 440 kDa on BN-PAGE, which would fit the early PP-b module 
intermediate, which has a size around 400 kDa (Guerrero-Castillo et al., 
2017). MITRAC15 also associates with MITRAC12 in the MITRAC complex 
(Mick et al., 2012). Interestingly, MITRAC15 is present in an additional 
uncharacterized complex around 70 kDa, which neither contains MITRAC12, 
nor ACAD9. Considering that MITRAC15 fulfils functions in complex I and IV 
assembly, this low molecular weight complex might represent a resting pool of 
MITRAC15, which can be utilized either in complex I or in complex IV 
assembly, with other uncharacterized subunits. 
Interestingly the presence of TIM21 restricted the interaction of MITRAC15, 
specifically with complex IV. When TIM21 was knocked down, an increase in 
MITRAC15 interaction with the MITRAC subunits was observed. However, 
there was no change in the interaction of MITRAC15 with complex I (Figure 
38). This observation also argues in favour of a free pool of MITRAC15, 
because the increased association of MITRAC15 with complex IV did not 
diminish its interaction with complex I. A TIM21 knockdown can contribute to 
the accumulation of MITRAC15 in the MITRAC complex in two possible ways: 
a) TIM21 acts as a shuttle to transfer imported proteins to the MITRAC 
complex for further assembly (Mick et al., 2012). Therefore, a knockdown of 
TIM21 would lead to slower complex IV formation, thus accumulating 
MITRAC15 in the MITRAC complex (Figure 45A). b) TIM21 performs general 
shuttle functions and actively transports MITRAC15 from the MITRAC 
complex to the free pool of MITRAC15. This is supported by the observation 
of Mick et al. (Mick et al., 2012) that the interaction between TIM21 and 
MITRAC15 remains the same regardless of whether TIM21 is shifted to the 






Figure 45 TIM21 promotes the disassembly of MITRAC15 from MITRAC. A) MITRAC15 
disassembles from MITRAC during further complex IV assembly and TIM21 indirectly causes 
the disassembly of MITRAC15 by promoting complex IV assembly. B) TIM21 directly shuttles 
MITRAC15 away from MITRAC to an ambient pool. 
A protein which is present in the early assembly intermediate of the PP-b 
module with MITRAC15 is ACAD9, making it one of the first interaction 
partners of MITRAC15 that is required for complex I assembly. The 
knockdown of ACAD9 impaired the assembly of the PP-b module and caused 
a lower association of MITRAC15 with ND2.The interaction of MITRAC15 with 
the MITRAC complex was not affectedunder these conditions (Figure 39). 
This result implies that MITRAC15 carries out its functions in complex I and IV 
independently and does not function in the crosstalk of both assemblies. It 
also suggests that MITRAC15 cannot be shifted directly between complex I 
and IV and hasto be returned to a free pool of MTIRAC15. The free pool of 
MITRAC15 is possibly represented by the low molecular weight MITRAC15-
containing complex at 70 kDa on BN-PAGE. To clarify the function of this 
complex, MITRAC15 containing complexes could be isolated and separated 
by BN PAGE. A mass spectrometry analysis would then provide an insight 
into the composition of the complex and functional analysis of these 
components could be carried out. Figure 46 shows a model of MITRAC15 






Figure 46Migration of MITRAC15 between complexes. MITRAC15 is likely to be 
transferred to an uncharacterized complex first after its function in complex I or IV assembly 
before participation in a new assembly event. 
 
Interestingly, a knockout of MITRAC15 did not affect the activity of the 
cytochrome c oxidase (Figure 42).On the contrary, the assembly of the late 
subunits of complex IV, such as COX6A, was even increased in MITRAC15-/- 
cells. Therefore, MITRAC15 might be involved in quality control of complex IV 
assembly. Since the activity of complex IV was not affected in MITRAC15-/- 
cells, other aspects of complex IV functionality, such as the production of 
reactive oxygen species (ROS) have to be analysed. A possible reason to 
stall complex IV assembly is to define the fate of the complexes, whether they 
will remain as monomeric complex IV, or assemble into one of the super 
complexes. In this scenario, MITRAC15 might retain complex IV biogenesis 
until the other complexes can be provided for supercomplex formation. 
Supercomplex formation is known to enable a higher efficiency of electron 
transfer (Bianchi et al., 2004) and reduce ROS production (Lopez-Fabuel et 
al., 2016). These processes could be assessed in MITRAC15-/- cells to 
investigate the putative effect of complex IV association and disassembly 
processes. But it has to be considered that measurements of cellular ROS 
would not be able to discriminate the source of the ROS production. 
Nevertheless, MITRAC15 is the first characterized protein acting in human 




Furthermore, considering its presence in an early PP-b module assembly 
intermediate the role of MITRAC15 was also assessed in the assembly of 
mitochondrial complex I.Since in MITRAC15-/- cells ND2 synthesis is 
decreased by 44 %, it can be concluded that MITRAC15 is possibly involved 
in the synthesis of ND2 (Figure 41). Comparing this effect to a knockout of 
assembly factors such as C12ORF62, which abolish COX1 synthesis 
completely (Sven Dennerlein, unpublished data), MITRAC15 might only play 
an assisting or regulatory role in ND2 synthesis. Therefore, another 
translation factor may exist for the synthesis of ND2. Possible candidates 
would be other assembly factors present in the early assembly complex of the 
PP-b module (ECSIT, NDUFAF1). These have to be investigated with regard 
to ND2 synthesis. Even though a knockdown of ACAD9 also caused a 
decrease of ND2 synthesis (Figure 39), it more likely plays an indirect role in 
ND2 synthesis, considering that ACAD9 does not interact with nascent chains 
of mitochondrial synthesized proteins(Figure 37). Furthermore, ribosome-
association of MITRAC15 was shown in an experiment performed by Ricarda 
Richter-Dennerlein(Richter-Dennerlein et al., 2016; unpublished data, 
Richarda Richter-Dennerlein). MITRAC15 shows strong interaction with newly 
synthesized ND2 and can copurify nascent chains of mitochondrial-
synthesized proteins (Figure 37). The nascent chains most likely belong to 
ND2, but have to be further characterized. Therefore, MITRAC15 most likely 
associates with ND2 during its translation, while ACAD9 joins after 
dissociation from the mitochondrial ribosome. Despite showing strong 
interaction with newly synthesized ND2, ACAD9 does not copurify putative 
ND2 nascent chains. This suggests that ACAD9 acts downstream of 
MITRAC15, during the assembly of the PP-b module. Nevertheless, ACAD9 is 
crucial for the assembly of the PP-b module, which is shown in Figure 39 and 
was also reported by Nouws et al. (Nouws et al., 2010). Unlike ACAD9, 
MITRAC15 is unlikely to play a role in PP-b module assembly. Despitecausing 
a decrease of ND2 synthesis by 44 %, the knockout of MITRAC15 did not 
lead to a decrease in complex I activity. Also it is debatable to which extent 
MITRAC15 stays associated with the assembling complex I. Guerrero Castillo 
et al. (Guerrero-Castillo et al., 2017) reported the presence of MITRAC15 and 




detected in the 2D analysis of isolated ACAD9 containing complexes 
presented in this thesis (Figure 35). Therefore, it is plausible that MITRAC15 
may leave the assembling PP-b module in its early stages. Furthermore, the 
stability of complex I activity, despite the 44 % decrease of ND2 synthesis, is 
in itself an interesting phenomenon. Even though the electron transfer from 
NADH to ubiquinone, which was measured by the complex I activity assay 
(Figure 42), is performed by the N and Q module, Stroud et al. showed that 
the PP-b module assembly is crucial for the stability of complex I. In the 
absence of the PP-b module accessory subunits NDUFC1 or NDUFC2, 
complex I assembly cannot proceed(Stroud et al., 2016). Therefore, it is 
unlikely that complex I can assemble without the PP-b module core subunit 
ND2. This suggests that 44 % ND2 is enough to sustain WT levels of complex 
I activity.Figure 47shows the revisited early assembly of the PP-b module. 
 
 
Figure 47 Early assembly of the PP-b module. MITRAC15 and possibly another assembly 
factor (assembly factor X) associates with the ND2 translating ribosome. After disassociation 
from the ribosome, ACAD9 joins other assembly factors promoting further assembly of the 
PP-b module. Assembly factor X may or may not stay with the assembly intermediate. 
 
Comparing OXPHOS assembly factors in yeast and human, some of the 
homologues still perform their conserved functions, like the heme A insertases 
COX10 and COX15 (Soto et al., 2012;Antonicka, 2003;Antonicka et al., 
2003). Other assembly factors, like Cox14/C12ORF62 and Coa3/MITRAC12, 
have diverged in their function from yeast to human, but still remain in the 
same assembly pathway (Mick et al., 2012;Richter-Dennerlein et al., 2016). In 
the case of MITRAC15, which shows a sequence similarity of 16.2 % 
(determined with the Needleman–Wunsch algorithm (Needleman and 
Wunsch, 1970) with the BLOSUM62 matrix (Styczynski et al., 2008)) to its 




characterized as an assembly factor which functions with Shy1, Mss51 and 
Cox14 in early to intermediate stages of complex IV assembly. Depletion of 
Coa1 causes strong defects in complex IV assembly and decreases the 
steady state levels of complex IV core subunits (Mick et al., 2007). MITRAC15 
on the other hand, acts as a translation regulator and possibly also assembly 
factor in the assembly of complex I, a complex not existent in yeast. 
Furthermore, the function of MITRAC15 in complex IV assembly also changed 
from a crucial assembly factor to a factor stalling the complex IV assembly. 
Hence, MITRAC15 should not be characterized as a homologue of Coa1, but 
as a new human assembly factor, which is not present in yeast. 
Nevertheless, the function and mechanisms of MITRAC15 need to be 

























Summary and conclusion 
 
For an efficient assembly of those complexes, the translation in mitochondria 
and cytosol have to be coordinated. Mitochondrial translation regulation 
factors of cytosolic translational origin are an important component in the 
crosstalk between mitochondria and the cytosol. Despite many mitochondrial 
translation regulators are characterized in yeast, little is known about their role 
in human mitochondria. This work provided insight into the assembly of the 
early MITRAC complex during COX1 translation and established MITRAC15 
as a translational regulator for the synthesis of the mitochondrial complex I 
core subunit ND2.   
During this work, the mitochondrial ribosome associated form of the MITRAC 
complex (MITRACribo) could be isolated. MITRACribo was analyzed by Western 
blot, mass spectrometry and cryoEM. The results obtained in the analysis 
show COX4I-1 as a subunit of MITRACribo. This implies that the early 
assembly of the cytochrome c oxidase already starts during COX1 translation. 
Furthermore, MITRACribo was could be localized near the exit tunnel of the 
mitochondrial ribosome and the insertase OXA1L could be identified as a 
subunit, which imply a role of MITRAC in coordinating the insertion of COX1 
into the inner mitochondrial membrane. Crosslinking data has to be generated 
to provide insight into a more detailed composition of MITRACribo. 
MITRAC15, a protein that act in both complex I and IV assembly, could be 
characterized more detailed in its function. MITRAC15 was shown to stall the 
assembly of the cytochrome c oxidase, while it could be identified as a 
translation regulator important for the synthesis of ND2. Because MITRAC15 
interacts with the mitochondrial ribosome, copurify nascent chains of 
mitochondrial synthesized proteins under puromycin treatment and show 
strong interaction with newly synthesized ND2, it is likely to associate with the 
ND2 translating mitochondrial ribosome. Finally, the complex I assembly 
factor ACAD9 could be shown to mediate the assembly of ND4L and ND3 into 
the PP-b module. However, the mechanism how MITRAC15 functions still has 
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